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                                                  ABSTRACT 
 
BACKGROUND 
Hypertensive disorders of pregnancy complicate almost 7-10% of all 
pregnancies. The development of hypertension and proteinuria after 20wks of 
 
gestation is referred to as pre eclampsia. It is a major cause of maternal  
 
morbidity andmortality and is also associated with increased perinatal  
 
problems. 
 
Recent studies have shown the relationship between the aggravation of  
 
Thehypertensive complications and the change in concentration of various  
 
chemistries inmothers serum. Interestingly, variable serum calcium,  
 
magnesium and uric acid levelsare found in pre-eclamptic mothers. 
 
Studies have also demonstrated the diagnostic value of Albumin  
 
Creatinineratio (ACR) in a single voided urine sample for quantification of  
 
proteinuria,compared to those of 24 hours of sample in patients with pre- 
 
eclampsia. 
 
 
OBJECTIVES 
 
1. To estimate the strength of association between the changes in the 
serum uric acid, serum calcium, urine albumin creatinine ratio in pre 
eclampsia. 
2. To know whether these factors in pre eclampsia influence on maternal 
and  perinatal outcome. 
 
Materials and Methods 
 
The study included 50 pre-eclamptic patients, and 50 normal pregnant  
 
Women in the age group of 18-35 yrs between 28 – 32 weeks. Serum calcium,  
 
uric acid and spot urinaryalbumin creatinine ratio were estimated in these  
 
subjects. 
 
Serum calcium was estimated by Arsenazo-III, Serum uric acid was  
 
estimated byenzymatic colorimetric method, Urinary albumin was estimated  
 
by immunoturbidimetricmethod and Urinary creatinine was estimated by  
 
colorimetic method. 
 
Results 
 
The serum calcium in pre-eclamptic women was significantly lower 
 
(8.29 ± 0.69mg/dl), in comparison to controls whose value was 9.73 ±  
 
0.72mg/dl(p<0.001)) and serum uric acid in pre-eclamptic women was  
 
significantly higher (6.7 ± 1.7 mg/dl) in comparison to controls whose value  
 
was 4.26 ± 1.03 (p<0.001). The Urinary albumin/creatinineratio in pre- 
 
eclamptic women was significantly higher (157.8± 48.7 mg/g) in  
 
comparison to controls whose value was (28.1± 25 .1 mg/g)  
 
(p<0.001). 
 
Conclusion 
 
In pre-eclampsia, the serum levels of calcium, magnesium, uric acid are 
 
altered, and spot UACR is significantly increased, suggesting strong association  
 
between these factors and severity of pre-eclampsia. 
  
Thus it can be concluded that , the careful monitoring of these markers in 
pregnant women may help in the mortality and morbidity reduction and thereby 
helpful  in the favourable outcome of the pregnancy. 
Key words 
 
Serum calcium, uric acid, urinary albumin-creatinine ratio, 
 
microalbuminuria, pre-eclampsia, pregnancy induced hypertension. 
 
 
  
INTRODUCTION 
 Pregnancy is the most important period  in women life, but it can be 
dangerous also. Pregnancy is a physiological state with profound alterations in 
biochemical and mechanical process. If the pregnancy has no complications, the 
biochemical changes are reversible soon after delivery1. Hypertension and 
proteinuria are the important complications of pregnancy2.  
 Pre eclampsia is defined as the presence of  systolic blood pressure more 
than 140 mm of Hg and diastolic pressure more than 90 mm of Hg , along with 
proteinuria , edema or both in a pregnant women . It usually occurs after 20th 
weeks of pregnancy or sometimes earlier when there is multi-fetal pregnancy or 
extensive hydatiform changes in the chorionic villi3. 
 It normally occurs in about 5- 10 percentage of pregnancies. It is a 
pregnancy specific disease and is associated with high maternal and fetal 
morbidity and mortality. Pre eclampsia once developed is progressive till 
delivery. 
“Berg and colleagues reported that 16% of 3201 maternal death in the 
united states from 1991 to 1997 were complications of gestational induced 
hypertension . During this study, black women had 3% times higher mortality 
compared with the white women.4 
 
  
 Pre eclampsia in its severe form may be associated with cerebral or visual 
disturbances , oliguria , elevated serum creatinine & serum uric acid along with 
the presence of epigastric pain.  
  The blood pressure elevation may be the most important  tool for the 
identification of the pre eclamptic women. The peripheral edema may occur 
thereafter. The regular blood pressure recordings are essential for clinching the 
pre eclamptic women.  
The visual disturbances , although not a very common presentation, but it 
may occur as a result of pre eclampsia in the pregnant women. But once visual 
changes accompanies the elevated blood pressure and proteinuria  or edema , it 
rings the alarm for the presence of  pre eclampsia.  
 These changes when accompanied with convulsions without pre existing   
neurological disease like epilepsy and it may lead to eclampsia. When the 
seizures accompanies the elevated blood pressure , proteinuria or edema , it may 
result in eclampsia. 
 The pathophysiological mechanism is characterized by a failure of the 
trophoblastic invasion of the spiral arteries, leading to the maladaptation of the 
maternal spiral arterioles which may be associated with increased vascular 
resistance of the uterine artery and decreased perfusion of the placenta5. 
  
 The spiral arterioles plays an significant role in the pre eclampsia. The  
structural and physiological changes in the normal spiral arterioles may lead to 
the development of the pre eclampsia.  
 The progression of the pre eclampsia  with the cerebral, vascular and the  
changes in the uric acid levels explains its severity. The  peripheral edema in the 
pre eclamptic women is due to the altered albumin levels and it leads to oncotic 
pressure changes and so the edema. 
 The precise cause of the vascular endothelial dysfunction , an important 
factor in the pathophysiology of pre eclampsia remains unknown6. 
 The reults from many clinical studies show the relationship between the 
aggrevation of hypertensive complications  and the change in concentration of 
various chemicals in mother’s serum. Interestingly , variable levels of serum 
calcium and serum uric acid levels are found in pre eclamptic mothers7,8. 
 The lowering of serum calcium and increase of intracellular calcium can 
cause an elevation of blood pressure in pre eclamptic mothers. 
 Besides serum calcium hyperuricemia is believed to result from the 
decreased renal excretion that occur as a consequence of the pre eclampsia, also 
increased production may be secondary to tissue ischemia and oxidative 
stress9,10. 
  
 Soluble uric acid impairs nitric oxide generation in the endothelial cells. 
Hyper uricemia induces endothelial dysfunction and may induce hypertension 
and vascular disease. 
 Therefore the alteration of calcium and uric acid during pregnancy could 
be one of the potential causes of pre eclampsia. 
 Besides the blood pressure monitoring, urine albumin creatinine ratio also 
helps in the prediction of the pre eclamptic women. The pre eclamptic women 
urine sample is usually loaded with microalbumin  and the creatinine. This 
helps in the detection of  pre eclampsia .  
The studies have also demonstrated the diagnostic value of the 
albumin/creatinine ratio in a single voided urine sample for quantification of 
proteinuria compared to those 24 hours of sample in patients with pre 
eclampsia11. 
 Hence in this study, we propose to estimate and compare the serum levels 
of calcium ,uric acid and urinary albumin – creatinine ratio in normal pregnant 
women  and pre eclamptic women. 
Maternal complications include  
o Abruptio placenta 
o Acute renal failure 
o HELLP 
  
o Convulsion 
o Occipital lobe  blindness 
o Pulmonary edema  
o Possible complications of caesarean sections 
Fetal complications include 
o Prematurity 
o Intrauterine growth retardation 
o Intrauterine death 
o Fetal distress 
 The complications of severe pre eclampsia could be prevented by prompt 
diagnosis of high risk patients, antenatal care and timely intervention. 
 The fetal risks are very severe when the albumin and the creatinine levels 
are largely altered. The coagulation pathway also gets stimulated if endothelial 
injury occurs.  
When the pre eclampsia sets in a very early trimester , close monitoring 
of the pregnant women is necessary. If the pre eclamptic women is on regular 
follow up and prompt medications the risks are greatly reduced. The utero 
placental  circulation is also safeguarded by controlling the blood pressure. 
The low platelet count in the  pre eclamptic women may results in the 
severe bleeding tendancies. It occurs as a result of  the alterations in the 
  
coagulation factors and fibrinogen. When this stage sets in the maternal and 
fetal lives are at great risk. The  periodic monitoring of the maternal serum for 
the platelet level and hepatic enzymes  explains the necessity for avoiding 
complications. 
 Termination of pregnancy is the treatment of  severe pre eclampsia. The 
risk  of the fetal and maternal  lives are more in the continuation of pregnancy. 
So termination is usually preferred in this situation. The possibility of  
progression of pre eclampsia  to eclampsia is also more in uncontrolled 
hypertension. 
 The identification of the women at risk of pre eclampsia  is essential in 
the antenatal period. The prompt treatment at the initial stage may prevent  
severe  morbidities for both mother and baby. 
 The identified cases of pre eclampsia should be on a regular follow up. It 
is usually advised  for regular blood pressure monitoring ,  blood and urine tests 
from the first trimester itself. This is because  pre eclampsia usually occurs in 
2nd trimester in many pregnant women. But in rare cases it starts from the first 
trimester also. 
 There are several methods to identify the women who are at risk of pre 
eclampsia which includes roll over test, isometric hand grip exercise test, 
angiotensin II pressor response and mean arterial response test. However , these 
  
tests have certain limitations  for screening because of false positive results and 
subjective nature of result interpretation. 
Pregnancy induced hypertension complicates 5-10% of all the 
pregnancies. In the developed  countries, 16% of the maternal mortality isdue to 
hypertensive disorders. Therefore early detection of pregnancy induced 
hypertension &appropriate management is a must to decrease both maternal and 
perinatal morbidity and mortality. 
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REVIEW OF LITERATURE 
HISTORY 
 The history of eclampsia starts from Hippocratic writings(430-330 BC). 
In the year (384 – 322 BC) Aristotle  was the first to realise that the fetal 
nutrients are transferred through the umblical cord , which is the only source of 
connection between the mother and fetus. He also realised that the fetus is fully 
surrounded by membranes. De-La Motte , in the year 1726, considered  that 
unless associated with convulsions , the oedema is mostly benign37. 
 During 18th century, the idea of proteinuria linked with eclampsia was 
identified and in the same period, the association between the oedema, headache 
and blurred vision were also remarked. 
 In the 19th century, the pre eclampsia was studied in a large manner. As a 
result of these researches, hypertension was identified as an important factor in 
the pre eclampsia. The triad of oedema, hypertension and proteinuria which 
often precedes the convulsion was came to known as pre eclampsia. 
 In the  year 1924,  renowned scientist husselman identified that a 
primigravida  is eight times more prone to have eclampsia in her pregnancy than 
multigravida. He also found there isa  six fold  increased risk of eclampsia in 
twin pregnancy. 
  
 In the year 1926- 1936, Herrick and co workers  found that the essential 
hypertension is a highly associated  factor in the hypertensive disorders of 
pregnancy.     
 Dickmann 1952,  found that when  hypertensive disorders are present in a 
pregnant woman,  she may have either nephritis or essential hypertension. 
 Redman 1991, attributed  pre eclampsia to be an inadequate response of 
the mother to the fetus. Gill  in 1994, postulated  the familial nature in the pre 
eclampsia patients38 
Ferrazzani and coworkers reported that the perinatal morbidity and 
mortality increased with the combination of proteinuria and hypertension. Their  
study was based on the proteinuric pregnant women and their pregnancy 
outcomes. 444 pregnant women were studied. They found that there was a four 
fold increase in perinatal mortality rate in proteinuric pre eclampsia than in the 
chronic hyper tension and non proteinuric gestational hypertension.  
 Ginsberg et al , in his researches found that the amount of protein 
excreted in the urine is of diagnostic importance. 
Pederson  EB and co workers in 1984, worked on the serum calcium in 
(1)normal preganant women, (2) patients with pre eclampsia and (3)non 
pregnant control subjects39. Serum calcium  was reduced  in pre eclampsia, the 
serum calcium was not differed markedly when compared with normal pregnant 
  
group. It was concluded that   both normal pregnancy and pre eclampsia have 
significant variations in calcium metabolism. 
Saudan et al in their study have emphasized the need for quantitation of 
proteinuria. The morbidity increases with the nephrotic range proteinuria. 
Rodriguez  H M and coworkers (1988), examined first morning urine 
sample in 88 normotensive gravid women between 24 to 34 weeks for the 
presence of microalbuminuria40. Receiver operator curve  was used. Pre 
eclampsia was predicted using the value  of 11µg/ml. Albumin level of ≤ 
11µg/ml  was found in five on ten pregnant women who developed pre 
eclampsia and also on fourteen normotensive pregnant women. the test gave a 
specificity of 99%, sensitivity of 50%, PPV of 83% and NPV of 94%. 
Oscar E and coworkers(1990), examined protein/creatinine (mg/g) ratio 
in random urine samples. The study people included were  35 pre eclamptic 
women and 70 healthy pregnant women41. The ratio did not exceed 200 mg/g in 
any of 70 healthy pregnant women and therefore ratios below this value  can be 
considered as normal. 
Misiani R and coworkers (1991),  examined if  the microalbuminuria  
could be an early reliable indicator for the pregnancy induced hypertension to 
evaluate the effects of physical activity on the excretion of albumin in normal 
pregnancy and pregnancy induced hypertension42. The study was done on 67 
  
healthy primi gravidae , from 16 to 36 weeks of gestation and 12 weeks of post 
partum. Among which, 55 completed normal pregnancy and 12 developed  
pregnancy induced hypertension. The day time urinary albumin excretion was 
found to be significantly higher in the pregnancy induced hypertension 
developed patients(p value between less than 0.005 and less than 0.001) than in 
normal primigravidae (p value between less than 0.01 and less than 0.001).  The 
hypertension developed after the urinary albumin is found to be increased. 
Kenneth higby and co workers 1994, measured the normal 24 hour 
excretion values of urinary albumin and total protein in healthy pregnant 
women43. 260 mg/ 24 hour of urinary protein and 29 mg/24 hour of albumin  as 
the upper limit of normal pregnancy was supported by this data. 
Phillip N baker and co workers (1994), examined  both urinary albumin 
creatinine ratio and urinary calcium/ creatinine ratio from single void urine of 
500 normotensive nulliparous women at 19 weeks of gestation44.  The result 
was found to be not with much differences in these two ratios in the 
preeclampsia  patients and normotensive patients. 
Risberg  A and co workers (2004) , researched for the measurement of  
spot  urine albumin creatinine ratio to be a alternative to the dipstick and the 
wastage of time in 24 hour urine samples examinations. 24 hour urine samples 
were collected in 12, 24 and 36 weeks of gestation from (1)normal pregnant 
women, (2)who developed pre eclampsia  during the study,  and (3) PIH 
  
pregnant women  at the time of entering the study45. Microalbuminuria was 
found to be  in three persons among PIH group and two persons in 
normotensive group. Severe albuminuria (>300mg/24 hours ) was  seen in one 
of the 46 normotensive patients(2%) and in 3 of the 19 PIH patients(16%).  The 
albumin excretion  in the urine was identified by the albumin creatinine ratio 
during  pregnancy. The results found that the urinary albumin creatinine ratio  
was found to be an better alternative to the 24 hour urine collections. 
Neithardt et al , in his study on 30 pregnant women, for the prediction of   
pre eclampsia by the single void urine protein creatinine ratio as an alternative 
to the 24 hours urinary protein sample estimation.  In this study, it was clealy 
stated that the estimation of 24 hours urinary protein might be a cumbersome 
and time consuming job. The 24 hours urine sample collection was started 
before mid day and blood for creatinine at the same time. A single void urine 
sample collected after 24 hours sample collection immediately. Biuret test for 
protein and Jaffe’s test for creatinine.  The conclusion was there is a significant 
association in both the tests with a r = 0.93 and p  <0.001 and the protein 
creatinine ratio  was also useful . 
Ginsberg et al explained the merits of  single void urine sample protein 
creatinine estimation over the 24 hours sample collection in a stable GFR 
pregnant women. 
  
Nissel H and co workers (2006) measured for the accuracy of spot urine 
albumin/ creatinine  ratio in pregnant women with hypertension.urine albumin 
creatinine ratio and albumin excretion >300mg /day were examined in 54 
pregnant women with hypertension46. The study shown that the stastically cut 
off value of 27mg/mmol was closely related  with 24 hours urinary albumin 
excretion. It was shown that the spot urine albumin / creatinine sample 
examination could be a better alternative to the 24 hour urine sample collection. 
Frank p.schubert and co workers (2006) measured random  protein 
/creatinine ratio as a predictor of significant proteinuria (≥300mg/24 hour) for 
the evaluation of pre eclampsia. A protein/creatinine ratio of ≤0.15 rules out  
significant proteinuria  and may easily clinch the pr eclampsia47. 
Daya sirohiwal and co workers (2009),  evaluated the 24 hours urinary 
protein and calcium in the prediction of pre eclampsia. 200 normotensive 
pregnant women were examined48.  Among which, 21 women developed pre 
eclampsia. In that 21 pre$ eclamptic women, 13 were of mild pre eclamptic type 
and 8 were of severe pre eclampsia. The pre eclampsia was more prone in  
women with increased 24 hour urinary protein level.  
Roberts J M  (1997 - 2002) studied on 972 pregancies  in a nested casse 
control study and reported that the hyperuricemia is an important tool for 
diagnosing  gestational hypertensive disorder of pregnancy as equal to 
proteinuria. 
  
Punthumapol C and kittichotpanich B (2006- 2007), in their studies, 
reported that there is a significant association of increased serum uric acid level 
and pre eclampsia49. 
Johnson RJ et al (2003), assessed the link between the vascular disease 
and uric acid level and proposed the possible mechanisms of the uric acid effect 
in the endothelial dysfunction by inducing anti proliferative effects and 
impairing nitric oxide synthesis, inducing the vascular smooth muscle 
proliferation and synthesis of C reactive protein, increasing platelet 
adhesiveness and lysis, thrombus formation, oxidative stress and free radical 
formation and lipid peroxidation50,51. 
Bainbridge S A  et al (2009) , studied the pre eclamptic patient’s uric acid 
levels and reported the elevations in the circulating uric acid plays vital role in 
the disease pathology through the attenuation of  trophoblastic invasion and 
vascular remodelling in spiral arteries52. 
Saleh F et al (2010) conducted case control study and reported that the 
elevated serum uric acid levels plays a vital part in detection of pre eclampsia53. 
Hawkins TL-A et al (2011) studied on the role of uric acid levels in the 
maternal and fetal outcome. They reported that  hyperuricemia is an important 
finding in predicting adverse outcome and its role in women with gestational 
hypertension without any feature of pre eclampsia54. 
  
They concluded that the serum uric acid examination in the pregnant 
women is an useful and inexpensive marker of predicting preeclampsia and fetal 
growth restriction. 
Chanvitya  and co workers (2006 – 2007 ) studied on the pre eclampstic 
mothers and found the serum levels of calcium is decreased. Hypocalcemia was 
also an important factor in the pathogenesis of pre eclampsia55. 
Idogun ,Imarengiaye , momoh (2007)  did  a study on the calcium levels 
in  pregnant women and found that the calcium levels of  pre eclamptic women 
were found to be reduced56.  
Sukonpan and phupong v (2005) , in their study on 40 pre eclamptic 
women and 40 normal pregnant women, found that  hypocalcemia is present in 
the pre eclamptic women serum57.  
Selhattin kumurul and co workers (2002) studied on the calcium and its 
role in the pre eclamptic mothers and found that hypocalcemia is present in the 
maternal serum58. 
Geeta krishnamoorthy B (2000- 2002) did a study on women  withmild 
pre eclampsia (121) and severe pre eclampsia (26) women and found the 
decrease in the maternal serum calcium levels59. 
  
Klaus and co workers (1998 ) studied on the serum calcium levels of 16 
pre eclamptic women  and 18 normal pregnant women. They  found the reduced 
calcium levels in  pre eclamptic women60. 
Standley  CA,  Whitty JE,  Mason BA (1997), studied on 31 pregnant 
ladies in first, second, third  trimester out of which nine who developed pre 
eclampsia showed  no change in the calcium levels61.   
Naser O, Malas and co workers (1998 to 2000) did  a study on 40 
pregancy induced hypertension women an 40 normal pregnant women. once the 
patient newly developed  hypertension in third trimester, and fulfilled the 
selected criteria she was enrolled in this study. The mean calcium level in the 
hypertension developed women was (8.22 ±0.12 mg%) when compared with 
normal pregnant women(9.50±0.16 mg %)62. 
Golmohammad lou  and co workers  studied on 52 women with pre 
eclampsia in their third trimester and 52 normal pregnant women.They 
concluded mean serum levels of calcium , magnesium , copper and zinc  are not 
significantly altered in the pathogenesis of pre eclampsia63. 
Seema jain and her co workers did  a study on the calcium , magnesium, 
and zinc levels in 50 pre eclamptic cases and normotensive controls.  Result 
came to be decreased levels of calcium in the pre eclamptic women64,65.  
 
  
HYPERTENSIVE DISORDERS IN PREGNANCY 
 Historically , this disorder was reported nearly 2000 years back when 
celus  reported as seizures in pregnant women that occur after delivery. 
 This abnormality was given the name “ECLAMPSIA” in greek which 
means lightening , because of its rapid and unexpected appearance12. 
 In the middle of 1800s,urinary examination  of proteins in pregnant 
women  with  eclampsia revealed that severe proteinuria may antedate the 
seizure. 
 In the later part of 1800s, when it become possible to measure blood 
pressure  with sphygmomanometer, it is apparent that, like proteinuria, in 
eclamptic  women, high blood pressure also antedated the seizures13. 
 The term pre-eclampsia was applied as proteinuria and hypertension 
which  antedated  eclampsia. 
 Hypertensive disorder complicating pregnancy are common and form one 
of the deadly triad, along with haemorrhage and infection, that continues to be 
responsible for increased maternal morbidity and mortality related to pregnancy. 
The  identification of the pre eclamptic pregnant women should be done 
as earlier as possible. Treating the pre eclampsia at the initial stages is easier 
when compared with treating  those  with  complications. 
  
Enhanced surveillance will help in diagnosing  high risk pregnant women 
and the  early detection  and  prompt  treatment  helps  to prevent  progression 
of the disease. Correct treatment at the early stages of the disease will help in  
good pregnancy outcome for both mother and fetus. However why pregnancy 
induces  this vascular disease remains an unsolved problem in obstetrics. 
CLASSIFICATION14 
 According to working group of National High Blood Pressure Education 
Program (2000) ,  hypertensive disorders complicating pregnancy are classified 
into 5 types 
1. Gestational hypertension 
2. Preeclampsia   
3. Eclampsia  
4. Pre-eclampsia superimposed on chronichypertension 
5. Chronic hypertension 
An important feature of this classification is that it differentiates pre-eclampsia 
and eclampsia  from other hypertensive disorders of pregnancy. 
 
 
 
  
GESTATIONAL HYPERTENSION 
It is defined as 
 Recording of systolic blood pressure ≥140 mm hg or diastolic 
blood pressure ≥ 90 mm hg first time in pregnancy after 20 weeks 
of gestation. 
 Not accompanied by proteinuria.Blood pressure returns to normal 
within 12 weeks of postpartum period. 
PRE- ECLAMPSIA 
It is defined as 
 Rise in blood pressure with proteinuria, edema may be present. 
 Proteinuria ≥ 300 mg per 24 hrs urine collection or 30 mg /dl. That 
is equivalent to 1(+) in dipstick tests in random urine samples 
It is classified in to two types, 
 Mild pre eclampsia 
 Severe pre eclampsia 
Pre eclampsia is considered as severe if any of the following is present 
 Systolic blood pressure  ≥ 160 mm hg or diastolic blood pressure ≥ 
110 mm hg. 
 Proteinuria 2.0 gm per 24 hrs urine collection samples. 
  
 ≥ 2 (+) in dipstick random urine samples. 
 Thrombocytopenia (platelets <1 lakh /µL ) 
 Symptoms like persistent headache, visusal distubances, epigastric 
pain. 
 Microangiopathic hemolysis- increased lactate dehydrogenase 
 Serum creatinine elevated 
 Pulmonary edema  
 IUGR  or Oliguric pregnant women. 
ECLAMPSIA 
This occurrence of generalised tonic clonic type of seizures in a women 
with pre eclampsia  is termed as eclampsia. It may not be attributed to other 
cause. It may occur before, during or after delivery. 
PRE ECLAMPSIA SUPERIMPOSED ON CHRONIC HYPERTENSION 
 New onset of  proteinuria in a women with chronic hypertension after 20 
weeks of gestation 
CHRONIC HYPERTENSION 
 Blood pressure ≥140/90 mm hg before 20 weeks of gestation or 
before pregnancy. 
 Diagnosed as hypertension after 20 weeks of gestation and 
persistent after 12 weeks  postpartum. 
  
INCIDENCE AND RISK FACTORS 
Pre eclampsia commonly affects young and nulliparous women. 
Incidences varies from 3 – 10 % in nulliparous women. Incidence of 
preeclampsia in multiparous women is less than that  of nulliparous. 
RISK FACTORS 
 Genetic predisposition – family h/o pre eclampsia 
 Age > 35 years 
 Interval from last pregnancy >10years 
 Obesity  BMI> 35 kg/m2  
 Multifetal gestation  
o GHT – 13 versus 16%  in singleton pregnancy 
o Pre eclampsia – 13 versus 5 % in singleton pregnancy. 
 Hydraminos  
 Vesicular mole  
 Hydropsfetalis  
 Chronic hypertension. 
 Maternal diabetes. 
 Renal disorders. 
 Antiphospholipid syndrome 
 Systemic lupus erythematosus 
 h/o smoking and abnormal uterine artery Doppler at 18 to 24 weeks. 
  
Age 
 Compared to younger women there is greater incidence of pre eclampsia 
in women older than 35 years. The incidence of pre eclampsia is 9.4 percentage 
in women >35 years old  when compared with 6.4% in women <35 years old. 
After 34 years, there is increase of 30% risk of pre eclampsia for every year 
thereafter. 
Genetic factors 
 In 1873, Elliot described the familial nature of the disease which was 
reviewed by chesley in the year 1968. He reported a patient who died of 
eclampsia. Both father and mother contribute  to the genetic risk. There is 
presence of increased susceptibility of inherited genes from the pre eclamptic 
mother to the foetuses, which are capable of triggering pre eclampsia. It is a 
multifactorial polygenic syndrome. Some of the genes responsible for this are  
o MTHFR gene affecting methylene tetra hydrofolate reductase 
o Factor V(leiden) gene 
o Angiotensinogen gene(AGT) 
o HLA genes causing immunological tolerance 
o NOS3  gene affecting endothelial nitric oxide production 
o F2 ( prothrombin factor II ) gene  
o ACE (Angiotensin converting enzyme) gene. 
  
ETIOLOGY 
Inspite of the researches over the years, the exact cause of pre eclampsia 
remains unknown.Gestational hypertension disorders  are very much likely to 
develop in women who15 
o Are exposed to chorionic villi for the first time 
o Are exposed to super abundance of chorionic villi , as with twins or 
hydatiform mole. 
o Has pre existing vascular disease 
o Are genetically predisposed to hypertension developing during 
pregnancy. 
According to sibai (2003), the potential causes include the following  
o Abnormal trophoblastic invasion of uterine vessels. 
o Immunological intolerance between maternal and fetoplacental 
tissues. 
o Maternal maladaptation to cardiovascular or inflammatory changes 
of normal pregnancy. 
o Dietary deficiencies. 
o Genetic influences. 
 
 
  
IMMUNOLOGICAL THEORY 
 The possibility that immunological as well as endocrine and genetic 
mechanisms are involved in the genesis of pre eclampsia. The risk of pregnancy 
induced hypertension is enhanced in circumstances where formation of blocking 
antibodies to antigenic sites on the placenta might be impaired or where the 
number of antigenic sites provided by the placenta is unusually great when 
compared with the amount of antibody as with multiple fetuses. 
 However some studies found no association of compliment fractions c3, 
c3F  with pre eclampsia.  
GENETIC THEORY  
 In the year 1979, cooper and liston revealed that preeclamsia is dependent 
upon a single recessive gene, but multifactorial inheritance cannot be excluded. 
DIETARY DEFICIENCY 
 Some of the workers implicated that the calcium  deficiency might be one 
of the cause of pre eclampsia. Studies have reported that dietary supplements of 
2gm of calcium per day after mid pregnancy reduce the incidence of 
preeclampsia. 
 
 
  
PATHOGENESIS 
 Women with pre eclampsia show changes in the vasomotor activity, 
plasma volume and coagulation system. Their disturbances had been attributed 
to the endothelial cell activation or dysfunction. 
 VASOSPASM16 
The basic pathophysiology of pre eclampsia and eclampsia is vasospasm. 
Vasoconstriction causes resistance  to blood flow and leads to the development 
of arterial hypertension. 
 ABSENCE OF SPIRAL ARTERIES REMODELLING 
“The inciting organ in the development of pre eclampsia is placenta” 
Uteroplacental vessels development proceeds into two stages 
o First stage  
 before 12 weeks post fertilisation : upto the interface 
between decidua and myometrium 
o second stage 
 between 12 to 16 weeks. It involves invasion of 
intramyometrial segments of spiral arteries. 
Normally the cyto trophoblasts of the developing placenta migrates 
through the decidua and myometrium & to invade the tunica media of the spiral 
  
arteries which supply blood to the fetus. So these changes leads to the 
transformation of small muscular arterioles to large low resistence vessels.these 
changes occur at the end of first trimester and completed  by 18 - 20 weeks of 
gestation. 
But in  pre eclampsia , cyto trophoblasts fails to penetrate the myometrial 
segment. So, the spiral arteries remains narrow and results in the hypoperfusion 
of the placenta which is the important component in  pre eclampsia 
pathogenesis. This placental ischemia causes maternal endothelial dysfunction. 
In the year 1980, dewolf and coworkers examined the arterioles from the 
placental implantation site using electron microscopy. They found that in ealy 
stages there is damage of endothelial cells, accumulation of lipids in the 
myointimal cells resulting  in narrowed lumen. 
 
  
Abnormal Trophoblastic Invasion Of Spiral Arterioles
 
 
  
IMMUNOLOGICAL INTOLERANCE17 
 There was a evidence to support that pre eclampsia is immune mediated.  
Immunologists  explained that the condition where there is abnormality of 
immune protective mechanism are shown to prevent the mother from rejecting 
fetuses. To support  this , there is decrease in incidence of pre eclampsia in 
patients who are immunosuppressed. Starting from the early second trimester, 
women who are at risk of developing pre eclampsia had significantly lower 
number of helper T cells compared with normotensive pregnant women. This 
Th1/Th2 imbalance was mediated by ADENOSINE, which is found to be 
higher in pre eclamptic mother  compared with normal healthy pregnant mother. 
The placental changes in pre eclampsia have shown some similarity 
which is found in the rejected kidney after transplantation. 
 “ The evidence that supports this theory is there may be loss of maternal 
tolerance to the paternally derived placental and fetal antigens”. 
  The placenta has both paternal and maternal halotypes and genetic 
determinants. Compared to the normal pregnant patients there is reduced level 
of messenger RNA for HLA-G has been noted in women with pre eclampsia. 
 Cytokines particularly TISSUE NECROSIS FACTOR(TNF α) and 
interleukin 2 (IL2) and interleukin 6(IL6) are the mediators of immune 
maladaptation in pre eclampsia patients. 
  
 ENDOTHELIAL CELL ACTIVATION 
If the endothelium is intact, it has anticoagulant property  and by 
releasing nitric oxide, it blunts  the vascular smooth muscle response to agonist. 
So endothelial cell damage secretes pro coagulants and there is less nitric oxide 
production and there is increased sensitivity to the pressor agents. 
Endothelial Cell Activation 
 
  
  
  
  
  
  
 PROSTAGLANDINS 
There is decreased production of PGI2 Prostocyclin in pre eclampsia 
compared with normal pregnancy. There is also an increased production of 
thromboxane A2 by platelets, so the prostacyclin : thromboxane ratio decreases. 
This leads to increased response to vasopressor angiotensin II and finally leads 
to vasoconstriction 
. 
  NITRIC OXIDE18 
Endothelial cells produces nitric oxide from L
vasodilator. Reduced nitric oxide synthesis in pre eclampsia increases mean 
arterial pressure & increases the sensitivity of vasopressor agents. The effect of 
nitric oxide production in pre eclampsia remains unclear.
 OXIDATIVE STRESS
This hypothesis states that , the pre eclampsia is due to the activated 
leucocytes in the maternal circulation. The decidua
cells which on activation re
α, leukotrienes , etc which are responsible for oxidative stress in the body.
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 ENDOTHELINS19 
Endothelin is a potent vasoconstrictor and it is the primary form produced by 
human endothelium. Endothelin levels are increased in pre eclamptic women 
compared with normotensive women. Some of the report shows that the 
magnesium sulphate decreases the endothelin I concentration. 
 ANGIOGENIC AND ANTI ANGIOGENIC PROTEINS 
 The balance between the angiogenic and anti angiogenic factors are 
responsible for the normal  development of placenta. 
 In the pre eclampsia, there is increased production of antiangiogenic 
factors which resultsin endothelial dysfunction. Researches are currently on the 
use of antiangiogenic proteins in the prediction and diagnosis of pre eclampsia. 
The two antiangiogenic proteins that increased in the maternal circulation are : 
a. Soluble endoglin: 
It is the 65 kDa molecule derived from placenta . This 
inhibits TGF-β isotopes from binding with endothelial 
receptors, which decreases the nitric oxide release from the 
endothelium. 
 
 
 
  
b. Soluble FMS like tyrosine kinase – 1 : 
It decreases the placental endothelial growth factor and 
vascular endothelial growth factor, which leads to the 
endothelial dysfunction. 
Both these antiangiogenic factors begins to rise in the maternal serum before pre 
eclampsia develops . 
Elevated level of antiangiogenic factors in second trimester is associated 
with increased risk of pre eclampsia .it is produced by the trophoblastic tissue , 
which enters in to the maternal circulation. So there is angiogenic imbalance. 
 RETENTION OF SODIUM 
 There is increased plasma volume , glomerular filtration rate and renal 
blood flow in normal pregnancy, but in pre eclamptic women, there is reduced 
plasma volume, renal blood flow and glomerular filtration rate. So there is  
retention of sodium occurs  which increases the sensitivity of vasopressor 
agents in pre eclampsia. 
All the signs and symptoms of pre eclampsia are well explained by response 
to generalised endothelial dysfunction. 
1. Increased vascular permeability leads to proteinuria and edema. 
2. Disturbed vascular tone of the endothelial cells leads to the hypertension. 
3. Expression of pro-coagulants leads to coagulaopathy. 
  
4. Endothelial dysfunction in the vasculature of brain, liver, kidney & 
placenta causes headache, seizures, epigastric pain, visual disturbances 
and fetal growth restriction 
5. In severe pre eclampsia , angiotensin II causes vasoconstriction which 
leads to local hypoxia  and causes haemorrhage & necrosis and other end 
organ damages. 
 
 
 
 
 
 
 
 
 
 
 
  
Overview of pathophysiology of pre eclampsia 
 
 
 
  
PATHOLOGICAL CHANGES 
 Pre eclampsia is a two stage disease . 
 Asymptomatic stage 
Abnormal placental development during first trimester. 
    
Placental insufficiency and release of placental materials in 
maternal circulation. 
 Symptomatic stage   
Hypertension, renal involvement, proteinuria. 
1. CARDIO VASCULAR SYSTEM 
 Blood pressure = cardiac output  X  total peripheral resistance. 
Normally cardiac output is increased during pregnancy, but it rises further 
in the patients with pre eclampsia. Total peripheral resistance decreases during 
normal pregnancy whereas in gestational hypertension it increases. This is the 
main cause of blood pressure in gestational hypertension. Normal or 
hyperdynamic ventricular function is presented in these women. 
In pre eclamptic women, there is an increased chance of pulmonary 
edema despite  the normal ventricular function  because of the alveolar 
 endothelial – epithelial leak that is compounded by decreased oncotic pressure 
pressure from low serum albumin concentration.
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HEMATOLOGICAL SYSTEM 
 In normal pregnancy, total blood volume increases because of expansion 
of plasma leading to physiological anemia of pregnancy. The expansion in 
blood volume is reduced in gestational hypertension. Decreased regional 
perfusion in gestational hypertension results in the hemoconcentration.  
 Contraction  of the intravascular space is associated with the vasospasm 
and subsequent hemoconcentration. Haematocrit increases with increased 
severity of pre eclampsia. An attempt to is made to expand the intravascular 
space by fluid therapy may increase the pulmonary wedge pressure and results 
in pulmonary edema because of capillary leak. 
  The main pathophysiology of pre eclampsia is the vasospasm , which 
results in the endothelial injury. The endothelial injury is responsible for the 
microangiopathic hemolysis. It results in fragmentation of red blood cells, 
thrombocytopenia and anemia. 
  It is associated with low levels of antithrombin III, high levels of 
fibronectin and low levels of α2 –antiplasmin. These factors can help in the 
diagnosis of pre eclampsia and it differentiates from the chronic hypertension. 
 
 
 
  
BLOOD AND COAGULATION 
 Among the haematological abnormality, thrombocytopenia is commonly 
identified in the women with pre eclampsia, it may be life threatening. 
 Activation of the platelets will lead to the endothelial dysfunction. 
The coagulation system is activated by the tissue factor that is present on the 
endothelium. This results in widespread  disseminated intravascular 
coagulation(DIC). 
THROMBOCYTOPENIA 
 Thrombocytopenia has been described by stancke in the year 1922, in the 
patients with pre eclampsia. The platelet count is routinely examined in all 
gestational hypertension patients. 
The  intensity  of  thrombocytopenia depends on the duration and severity 
of pre eclampsia. The platelet count < 1 lakh/µL indicates severe disease. The 
platelet count decreases on the first day after delivery, the reaches the normal 
level in 4 to 5 days. Lower the platelet count , there is higher the maternal and 
fetal morbidity and mortality. 
 
 
 
  
HELLP SYNDROME 
 In addition to thrombocytopenia and hemolysis, there is elevated liver 
enzymes level in the patients with severe pre eclampsia, it indicates 
hepatocellular necrosis. 
COAGULATION 
Following are some of the abnormalities noted in pre eclampsia 
• Decreased levels of antithrombin III 
• Decreased levels of protein c and s 
• Decreased plasma fibrinogen level 
• Increased levels of fibrin degradation products 
• Increased levels of fibrino peptides A & B 
ENDOCRINE SYSTEM 
 Angiotensin II , catecholamine and vasopressin play an important role in 
elevation of blood pressure and increase in vascular resistance. Vascular 
sensitivity to angiotensin II occurs 8 to 12 weeks prior to the onset of clinical 
symptoms of hypertension. 
 Indomethacin and aspirin are prostaglandin inhibitors decreases the 
vascular sensitivity to angiotensin II. 
 
  
RENAL SYSTEM20 
In pre eclampsia, there is reduced renal perfusionand glomerular filtration 
rate. It occurs due to increased resistance of renal afferent arterioles. Glomerular 
endotheliosis occurs which block the filtration barrier. Sodium concentration in 
urine is elevated. Fractional excretion of sodium urine osmolality and urine 
plasma creatinine ratio is an indication of pre renal involvement. 
 Serum uric acid concentration is elevated in pre eclampsia. It is due to the 
reduction in glomerular filtration rate and increased tubular reabsorption. In pre 
eclampsia there is decreased urinary excretion of calcium occurs ,therefore 
Hypocalciuria occurs. 
RENIN – ANGIOTENSIN – ALDOSTERONE SYSTEM 
 It is responsible for the maintainence of  blood pressure, sodium and 
blood volume status. In normal pregnancy, plasma renin concentration and its 
activity, angiotensinII and aldosterone levels are increased. Normally  pregnant 
women have reduced refractoriness to  angiotensin II effects. 
  But in patients with pre eclampsia, there is loss of refactoriness to 
angiotensin II effects. This is demonstrated as early as 18 to 22 weeks of 
gestation  by pressor response to infused angiotensin II. 
 
 
  
LIVER 
 The  commonly found pathological lesion in liver is periportal 
haemorrhagic necrosis in the periphery of liver. 
 In the following circumstances, liver involvement is clinically 
significantSymptoms manifest as right upper epigastric pain and tenderness 
associated with elevation of liver enzymes alanine transferase and aspartate 
transferase usually seen with severe disease. 
Elevation  of liver enzymes without symptoms are considered as markers 
of severe pre eclampsia. They ususally normalize within 3 days of delivery. 
Areas of infarction in liver form hepatic haemorrhage which in turn 
extend to form subcapsular hematoma. It is diagnosed using CT or MRI. 
Sometimes preeclampsia is confused with acute fatty liver of pregnancy, 
because it is also associated with hypertension, thrombocytopenia and elevated 
liver enzymes. 
The incidence of subcapsular liver hematoma is 1.6 percentage. 
BRAIN PATHOLOGY 
 The brain involvement in pre eclampsia was first described from the 
autopsy specimens. But CT, MRI and DOPPLER studies gives much more 
important information of cerebrovascular system. 
  
ANATOMICAL LESIONS 
  Intracerebral haemorrhage is seen in 60 percentage of eclamptic women 
and it is fatal in 30% of eclamptic women.cortical and subcortical petechial 
haemorrhage areother  lesions found in the autopsy of eclamptic women. 
 Some of the other lesions noted are haemorrhage in pons or basal ganglia, 
sub cortical edema, multiple non haemorrhagic areas of softening are seen. The 
microscopic appearance of vascular lesions consists of perivascular 
microinfarcts and haemorrhages and fibrinoid necrosis of arteriolar walls. 
CEREBROVASCULAR PATHOPHYSIOLOGY 
 There are two theories to explain the cerebral involvement in women with 
eclampsia. 
• The first theory explains that there is vasospasm in the 
cerebrovascular system. This is based on angiographic images of 
diffuse or focal segmental narrowing of vessels. So the diminished 
cerebral blood  flow results in ischemia, infarction and edema. 
• The second theory is postulated that if there is sudden elevation of  
blood pressure it may exceed the normal auto regulatory capacity. 
  There is disruption in the end capillary pressure which results in 
Vasogenic edema because of increased hydrostatic pressure, extravastation of 
plasma and red cells through the tight junctional opening. 
  
CEREBRAL BLOOD FLOW 
 Autoregulation is defined as the cerebral blood flowwhich  remains 
constant though there is a change in the cerebral blood flow pressure. Eclamptic  
seizures explains that  auto regulation is disrupted during pregnancy with pre 
eclampsia. 
 MRI shows that the cerebral blood flow during pregnancy is similar to 
that of non- pregnant levels until it decreases by 20 percent by late trimester. 
CLINICAL SYMPTOMS 
1. Headache  
Thought to be as a result of cerebral hyper perfusion, 50 to 75 
percentage of women had headache and 20 to 30 percentage have 
visual  symptoms which proceed on to convulsions. 
2. Convulsions 
3. Blindness  
It is rare in pre eclamptic women,  but complicates eclamptic 
convulsion.Generalised cerebral edema occur which may cause changes 
in the mental  status. 
 
 
  
VISUAL CHANGES 
Diplopia , blurring of vision and scotoma manifest  in severe pre 
eclampsia and eclampsia. Blindness is less common and it is reversible. These 
visual  changes arise from the  retina, visual cortex of occipital lobe and lateral 
geniculate nuclei. 
 Occipital blindness is known as amaurosis, (in greek – dimming ). Retinal 
lesions caused by retinal ischemia or infarction results in blindness known as 
purstcher retinopathy. Retinal detachment also cause altered vision. 
Occasionally it accompanies with cortical edema. Surgical treatment is not 
indicated and the prognosis is ususally good and vision returns to normal within 
a week. 
UTEROPLACENTAL PERFUSION 
Vasospasm  results in reduced uteroplacental perfusion which plays a 
important role in the pathogenesis of pre eclampsia. Previously studies were 
done to access the uteroplacental perfusion by peak systolic : diastolic  velocity  
ratios from uterine and umblical arteries in women with pre eclampsia. 
 
 
 
  
CALCIUM  
 “pregnancy is a state of calcium loss in which mother must provide 25 to 
30 gm of calcium that makes up the fetal skeleton at birth”  
 During the third trimester of pregnancy, fetal calcium demand increases 
because during this period fetal skeleton undergoes mineralisation. This demand 
constitutes more homeoststic stress for maternal calcium metabolism, but the 
maternal response to this demand have not been studied . 
 Calcium is the most prevalent cation in the body and it is fifth most 
common element. An average human body approximately contains 1 kg of 
calcium (24.95mol). 99% of the body’s calcium present in the skeleton , 
predominantly as the extracellular crystals of unknown structure. 
 Normal calcium concentration in plasma is approximately 
9.5mg/dl(2.38mmol/L). 
Calcium exists in three states 
o 50% is free ionised calcium 
o 40% is bound to plasma protein. 
 80% of which is bound  with albumin 
 20% of which is bound with globulin. 
o 10% is complexed with small ions. 
  
Biologically active form of calcium is free calcium and it is regulated by the 
parathormone (PTH) and 1,25 dihydroxycholecalciferol. 
 Calcium is classified physiologically as intracellular or extracellular 
calcium. Intracellular calcium plays an important role in physiologic functions 
such as hormone secretion , glycogen metabolism, muscle contraction and cell 
division. 
 Extracellular calcium provides calcium ions for the bone mineralisation, 
coagulation of  blood and plasma membrane potential. It influences 
permeability and excitability of plasma membrane. 
 When free serum calcium decreases there is increased neuromuscular 
excitability and tetany and increased serum calcium reduces neuromuscular 
excitability. 
HORMONAL REGULATION OF CALCIUM METABOLISM 
1. Parathyroid hormone21 
Low levels of serum calcium stimulate the secretion of  PTH  and 
increased levels of serum calcium inhibiting the effect of  PTH. 
There is an increased secretion of parathyroid hormone during pregnancy. 
It indicates that there is maternal adjustment to the expanding extracellular fluid 
volume and loss of calcium via placental transfer and urinary excretion. 
  
“ some studies suggest that the increase in PTH levels are limited to 
the last trimester and it is double the time of non pregnant values, 
whereas some studies proposed that there is gradual increase in the 
PTH level of about  30 % to  50%  at term.” 
2. Calcitonin22 
It is secreted by parafollicular cells (c-cells) of the thyroid gland.  It 
is a 32- aminoacid peptide. Increase in plasma calcium concentration , 
stimulate the secretion of calcitonin. It is also secreted in response to 
gastrin , secretin and glucagon. 
 It decreases calcium reabsorption from the kidney. 
 It decreases uptake from the intestines. 
 It increases deposition in bones.*** 
“during pregnancy, calcitonin secretion increases, thereby it protect the 
pregnant women skeleton from parathyroid hormone induced  resorption, but 
the PTH’s action in the kidney and gut is  never affected. 
3. Vitamin D 
It is taken in a preformed state or synthesized in the skin by the ultraviolet 
light action. 
 Some of the studies shown that altered calcium metabolism plays a role in 
the pathophysiology of pre eclampsia. So researches are focussing on 
  
prevention of pre eclampsia rather than the treatment. Among the prevention 
modalities, calcium and magnesium supplementation is included. 
 
 Various studies shown that there is relationship between the changes in 
concentration of various chemicals in mother’s serum and aggrevation of 
hypertensive complication. Significantly, the reduction is serum magnesium and 
calciumconcentration  was noted in pre eclamptic mothers23,24. 
 Severe alteration in calcium metabolism have been identified in the 
pathogenesis of pre eclampsia. Some of the metabolic abnormalities include, 
 Decrease in urinary calcium excretion  
 Decrease in serum 1,25-dihydroxycholecalciferol concentration. 
 Decrease in serum ionized calcium concentration. 
 Studies have shown that in pre eclampsia , there is an increased 
intracellular calcium in erythrocytes and platelets which results in 
vasoconstriction. 
 Indirectly calcium affects smooth muscle cell contractility by influencing 
the production of vasoactive agents such as prostacyclin, nitric oxide or 
angiotensin (renin – angiotensin pathway)25. 
  
 Renal excretion of calcium and phosphate increases during normal 
pregnancy. Excretion of calcium in normal pregnancy is 350- 650 mg/day 
compared with 100- 250 mg/ day in non pregnantal women26. 
 For each trimester, renal excretion usually increases, reaches maximum 
levels during 3rd trimester.Pre eclampsia is associated with hypocalciuria and 
many studies reporting that there is no such correlation. 
 Hypocalciuria results in significant increase in serum calcium levels, 
which activate phospholipase A2 to stimulate prostaglandin synthesis.  One of 
the study report that daily intake of  2000 mg calcium significantly lowers the 
incidence of toxemia27. 
MEASUREMENTS OF TOTAL CALCIUM 
 The methods routinely used for the measurements of calcium in clinical 
laboratories are  
o Photometric method 
o Ion selective electrodes method. 
o Atomic absorption photometry method. 
In 2004, college of American pathologist comprehensive chemistry survey, 
revealed that 79% of clinical laboratories used photometric methods and 20% 
used ion selective electrode method. 
  
 The reference intervals for total and free calcium in serum and plasma of 
adults: 
 Total calcium  - 8.6 to 10.2 mg/dl 
 Free calcium (ionized) – 4.6 to 5.3 mg/dl 
URIC ACID 
In humans, uric acid (2,6,8 – trihydroxy purine) is the major product of 
catabolism of purine nucleosides, adenosine and guanosine. Purines are formed 
from the catabolism of dietary nucleic acids and then converted to uric acid 
directly. Degradation of endogenous nucleic  acid was excreted as  uric acid. 
 Dietary source of uric acid contribute around 300 mg and the rate of 
synthesis of uric acid is approximately 400 mg. 
 The starting material for purine nucleotide synthesis is ribose 5 
phosphate, which is formed in the hexose monophosphate shunt pathway of 
carbohydrate metabolism. 
 It reacts with ATP and form phosphoribosyl pyrophosphate(PRPP). It 
regulates denovo purine synthesis. Glutamine transfers its amide nitrogen to 
phosphoribosyl pyrophosphate and produce 5 phosphoribosyl amine. The 
activity of the enzyme PRPP amido transferase is controlled by feedback 
inhibition of nucleotides(IMP, AMP & GMP). This reaction is the committed 
step in the purine nucleotide synthesis. 
  
 Inoline monophosphate is the first purine nucleotide formed by ring 
closure. Adenosine and guanosine monophosphates are derived from IMP 
through enzymatically mediated interconversions. 
CATABOLISM OF PURINES 
 It begins with removal of theirs ribose linked phosphate, a process 
catalysed by purine 5 nucleotidase. Hypoxanthine  and guanine are formed by 
the removal of ribose moiety of  inosine and guanosine by the action of purine 
nucleotide phosphorylase.xanthine oxide converts this xanthine to uric acid. 
 In general , uric acid stimulates the release of IL-6, IL-1β, TNFα and 
monocyte chemoattractant protein. It is an antioxidant. 
 The association between the pre eclampsia and increased serum uric acid 
concentration was first reported in the year 1917. 
 “Hyperuricemia in pre eclapmsia is evident from 1st trimester itself”. 
Elevated serum uric acid level is associated with adverse fetal outcome in 
hypertensive pregnancies28. 
 Uric acid is not only a marker for the severity of disease but it is directly 
involved in the pathogenesis of pre eclampsia . Uric acid causes endothelial 
dysfunction  inflammation and oxidative stress29. 
 Severity of pre eclampsia is directly proportional to uric acid level. Purine 
metabolism  by xanthine oxidase  is responsible for production of uric acid 
  
along with production of free radical super oxide(O2-), which is involved in the 
oxidative stress. The stimuli responsible for the xanthine oxidase activity 
remains unclear. 
 Hyperuricemia  was noted in 75% of women with clinically diagnosed 
pre eclampsia and 16% of women with gestational hypertension without 
proteinuria. Pregnancy induced hypertension with hyperuricemia was associated 
with increased adverse neonatal and maternal outcome. 
 Increased uric acid concentration even in the absence of proteinuria  may 
cause pre term birth and growth restriction. It is elevated in the serum as early 
as 10 weeks of gestation30. 
 Through the organic anion, Uric acid enters smooth muscle cells and 
activates intracellular  nuclear transcription factor and nitrogen activated protein 
kinase. It also stimulates the production of thromboaxane, angiotensin II and  c -
reactive protein. 
 The placental vessels has no autonomic innervation, it entirely depends 
on the locally produced circulating substance for hemodynamic control. 
 Uric acid reduces the eNos activity so that it decreases the nitric oxide 
production and increases the generation of potent vasoconstrictor 
thromboxane31. 
  
 Uric acid level is not uniformally elevated in women with pre eclampsia  
but it is increased in a subset of pre eclampstic women , they are at increased 
risk of maternal and fetal morbidities. 
Reference values  
o Male – 3.5 to 7.2 mg/dl 
o Female – 2.6 to 6.0 mg/dl 
During pregnancy: 
 Normally  uric acid concentration decreased during 1st trimester until 24 
weeks of gestation , then it begin to increase and exceed the value of non 
pregnant women. 
 Due to the effect of estrogen, increased glomerular filtration rate and 
increased blood volume there is a fall in the uric acid concentration   during 
early trimester. But in case of pre eclampsia, there is hypovolemia which 
increases uric acid reabsorption which increase serum uric acid level.  
o 1st trimester  - 2.0  to 4.3 mg/dl(Williams 23rd edition ) 
o 2nd trimester – 2.4 to 4.9 mg/ dl 
o 3rd trimester  - 3.1 to 6.3 mg/dl 
 
 
  
ALBUMIN – CREATININE RATIO 
 Proteinuria (albuminuria) is considered as an independent risk factor for 
renal disease and cardiovascular disease and as a predictor of end organ 
damage. 
 Detection of increase in protein excretion have both diagnostic and 
prognostic value in the initial detection and confirmation of renal disease and 
also helpful in assessing the progression of disease and the effectiveness of 
therapy. 
 An increase in protein excretion was used in the early detection of certain 
specific conditions such as pre eclampsia , diabetic nephropathy and 
nephrotoxicity due to drugs. 
 Proteinuria gradually increases throughout pregnancy and it is the result 
of selective glomerular filtration. 
 Normally, levels of 5mg/100ml in the first and second trimester and 10 
mg/100ml in the third trimester are normal. It may reach upto 300mg/day in a 
normal pregnancy in the third trimester. Values  in excess of 15mg/100ml or 
300mg/day are associated with pre eclampsia or underlying renal disease32. 
 Dipstick proteinuria was used as semiquantitative method, it is equivalent 
to 300mg/L, 2+ to 1g/L and  3+ to 3g/L  (RCOG). 
  
 Pre eclampsia is considered as severe if there is massive proteinuria of  
>5gm/day. It can be measured by quantification , either the total protein or of 
urinary albumin. So the increase in total proteins or albumin excretion is 
considered as aggravation of  pre eclampsia. 
 “ The present gold standard method for quantification of excreted 
proteins is by 24 hrs urine collection33” 
 The difficulties of 24 hour urine collection are well recognized however 
this test is unreliable in one third of cases. It is also a time consuming test. It 
also prolongs the hospital stay. So in our practice a rapid test may be needed. 
Therefore, detection of albumin in a single random urine sample may be an 
alternative to timed urine collections. 
 The excretion of protein and creatinine was reasonably constant 
throughout the day. When the glomerular filtration was stable some of the 
studies proposed that the measurement of protein to creatinine in urine samples 
collected over short time periods. 
 “ The Australian society for the study of hypertension in pregnancy and 
the international society for the study of hypertension in pregnancy have 
proposed the use of urinary spot protein- creatinine ratio  as an alternative to the 
24 hours urinary collection34”. 
 
  
COMPLICATIONS 
 Maternal  
o Central nervous system 
 Eclampsia 
 Cerebrovascular accident  
• due to intracerebral haemorrhage or occasionally 
intracranial aneurysmal rupture. 
 Retinal detachment 
 Cortical blindness  
o Respiratory system 
 Pulmonary edema with or without left ventricular failure  
It occurs due to excessive accumulation of fluid in the 
interstitial and alveolar spaces of lung. It develops in 
2.9% of pregnancies complicated by pre eclampsia. 
 Acute respiratory distress syndrome 
o Renal system 
 Renal cortical necrosis 
 Renal tubular necrosis 
 Renal failure  -It is characterised by marked reduction in the 
glomerular filtration which leads to increased retention of 
urea, electrolytes and acid base abnormalities. 
  
o Liver 
 HELLP syndrome 
It is associated with high maternal and fetal mortality. 
 Hepatic rupture35 
It is one of the most severe consequences of pre 
eclampsia. It occurs more commonly in the elderly 
women in their first pregnancy. The mechanism 
involved is 
 
Endothelial dysfunction + intravascular fibrin deposits 
 
Hepatic sinusoidal obstruction 
 
Increase in intrahepatic vascular congestion and pressure and 
Distortion of Glisson’s capsule 
 
Development of subcapsular hepatic hematoma and liver 
rupture 
 
  
 Fatty liver 
It is a rare disorder. It was first described by Sheehan 
in the year 1940 under the term obstetric yellow 
atrophy.  The currently accepted pathologic hallmark 
of the disease is “microvesicular hepatic steatosis”.  
o Haematological -  Disseminated intravascular coagulation (DIC) 
It is characterised by a increase in fibrinolysis and fibrin 
formation which leads to consumption of clotting factors, 
presenting as bleeding diathesis. Severe pre eclampsia was 
the most common cause of  disseminated intravascular 
coagulation. 
o Placenta – abruption placenta 
o Side effects of drug therapy. 
 
 Fetal36 
 “ Pre eclampsia is considered to be a maternal disorder in which the fetus 
is an incidental participant, but from the fetus point of view , it is a fetal 
disorder and mother  is an incidental participant.” 
 In congenitally normal singletons, pre eclampsia is the major cause of 
intra uterine growth retardation. It indicates a feature of early onsetsevere  
  
disease. Because of diminished utero-placental blood flow, there is anoxia 
which leads to liberation of thromboplastic substances from the placenta which 
initiates intravascular coagulation. 
 There are many types of lesions which are found in normal placenta and 
are more extensive in case of pre eclampsia which includes 
 Increased syncytial knots 
 Increased number of true infarcts. 
 Increased lose of syncytium  
 Proliferation of cytotrophoblast, villous necrosis. 
 Acute fibrinoid degeneration of maternal decidual arteries.  
As a result of this, there is  
 Increased secretion of chorionic gonadotropin 
 Increased secretion of steroid hormones 
 Deterioration of acute transport mechanism of vital aminoacids . 
All of the above factors contributes to fetal hypoxia and IUGR of fetus. 
 Intra uterine fetal growth restriction(IUGR) 
 Depends on the duration of hyper tension and the degree of 
proteinuria. 
 Antepartum and intrapartum asphyxia. 
• reduced placental blood flow. 
  
• Maternal hypoxia (due to eclampsia or excess 
sedatives or anticonvulsants). 
o Intrauterine death (IUD) 
o Prematurity – it is more likely to be iatrogenic in pre eclampsia 
o Fetal side effects of  anti hyper tensive therapy 
HELLP syndrome 
 In the year 1982, it was first coined by Weinstein. It comprises of 
 Hemolysis 
 Elevated Liver enzymes 
 Low Platelet count 
Incidence  
• 0.2 to 0.6 percentage of all pregnancy 
• 10 percentage of pregnancy complicated by severe pre eclampsia. 
Clinical features :Nausea , vomiting,  epigastric pain. 
Criteria  for diagnosis of  HELLP syndrome 
 Hemolysis  
• Abnormal peripheral smear – burr cells, schistocytes. 
• Bilirubin  >1.2 mg/dl 
• Lactate dehydrogenase  >600 u/L  
  
• Low serum haptaglobin 
 Elevated liver enzymes 
• SGOT - >70 U/L 
• LDH - >600 U/L 
 Low platelets - <1 lakh / mm3. 
 Differential diagnosis 
o Cholestasis of pregnancy 
o Acute fatty liver of pregnancy 
o Viral hepatitis 
o Haemolytic uremic syndrome. 
o Thrombotic thrombocytopenic purpura. 
Management  
 Termination of pregnancy is considered according to the gestational age 
severity of condition and favourability of cervix. Prophylactic anti convulsant 
and anti hypertensive  management are administered as indicated. 
  The platelet count and lactate dehydrogenase levels comes to normal by 
72 hours after delivery. So they are the best markers to follow the disease 
progression. There is increased risk of  20 % of developing gestational 
hypertension in subsequent pregnancy in the women with prior history of 
HELLP syndrome. 
  
ECLAMPSIA 
Pre eclampsia often proceeds the onset of eclamptic convulsions. It is a 
preventable disease. It is more common in primi. It is defined as 
“ development of generalised tonic clonic seizures/ coma in a pre 
eclamptic women in the absence other neurological conditions.” 
It is mostly associated with hypertension and proteinuria.  
Classification  
Eclampsia is one of the major cause of the morbidity and mortality in th 
pregnant women. It is classified into  
 Antepartum  eclampsia(38 %to 53%) 
 Intrapartum eclampsia(18 % to 36%) 
 Postpartum eclampsia(11% to 44%) 
It is more common in last trimester. Rarely it occurs before 20 weeks in cases of 
 Molar pregnancy 
 Multiple pregnancy 
 Antiphospholipid antibody syndrome. 
 
 
  
Incidence  
 In developed countries, 1 in 2000 deliveries are complicated by 
eclampsia. In developing countries, 1 in 100 to 1 in 1700 cases are complicated 
by eclampsia. But this incidence has now fallen dramatically because of  early 
detection and treatment. 
Warning signs  
• Persistent headache 
• Visual disturbances 
• Nausea / vomiting /epigastric  pain. 
• Restlessness and agitation. 
Stages of eclamptic seizures 
 It is characterised by prodromal, tonic, clonic and recovery stages. 
Prophylaxis  
 “The largest trial Magnesium sulphate for prevention of eclampsia 
(MAGPIE TRIAL collaborative group 2002), studied more than 10,000 women 
with severe pre eclampsia from 33 countries. Women who receiving magnesium 
sulphate had 58% lower risk of eclampsia than those given placebo. 
 Magnesium sulphate is Mgso4.7H2O  and not Mgso4. It is cleared by renal 
excretion. Therapeutic magnesium level is maintained at 4 to 7 meq/L, 4.8 to 
  
8.4 mg/dL or 2.0 to 3.5 mmol/L. Respiratory rate, patellar reflex and urinary 
output are monitored during Mgso4 therapy. It is not an anti hypertensive 
medicine. Regardless of renal function standard loading dose is given. But the 
maintanence dose may be decreased according to the urinary output. 
PREDICTION AND PREVENTION OF PRE ECLAMPSIA 
 Many attempts were made to find the early markers of impaired placenta 
perfusion, endothelial cell activationand dysfunction and faulty placentation. 
There is no valid screening test to predict pre eclampsia . 
  In the year 2009, conde-agudelo and  associates  provided  the review for 
the tests. 
Placental perfusion/ vascular resistance : 
o Roll over test 
o Isometric handgrip or cold pressor test 
o Angiotensin II infusion 
o Mid trimester mean arterial pressure 
o Platelet angiotensin II binding 
o Renin 
o 24- hour ambulatory blood pressure monitoring 
o Uterine artery  
o Fetal transcranial Doppler velocimetry. 
Fetal placental unit endocrine dysfunction 
  
o Human chorionic gonadotropin(hCG)  
o Alpha feto protein (AFP) 
o Estriol  
o Pregnancy associated protein A (PAAP A)  
o Inhibin A 
o Activin A 
o Placental protein 13 
o Corticotropin releasing hormone 
Renal dysfunction 
o Serum uric acid 
o Microalbuminuria  
o Urinary calcium or kallikrein 
o Microtransferrinuria 
o N-acetyl- β-glucosaminidase. 
Endothelial dysfunction/ oxidant stress 
o Platelet count and activation  
o Fibronectin  
o Endothelial adhesion molecule  
o Prostaglandins  &Thromboxane  
o c-reactive protein & cytokines 
  
o endothelins  & neurokinins B  
o VEGF, PlGF,PAI. 
o Leptin & p-selectin  
o Endoglin . 
Miscellaneous  
o Anti thrombin III  
o β 2  microglobulin 
o atrial natriuretic peptides. 
Mean arterial pressure 
 MAP = diastolic blood pressure + 1/3 pulse pressure 
 In women, who don’t have the normal fall in the blood pressure in the 
midtrimester, but the mean arterial pressure of 90 mm of Hg or more in the 
second trimester are at the risk of developing pre eclampsia.  
Roll over test 
 If there is increase in the diastolic blood pressure of 20mm Hg or more if 
the woman is turned from the left lateral to the supine position , the test is 
considered as positive. 
 
 
  
Angiotensin sensitivity test 
 In case of pre eclampsia there is loose their refactoriness to angiotensin 
between 28 to 32 weeks of gestation. The test is based on this above fact,that is 
if a pressor response occurs with  <8ng/kg/min of the infused angiotensin , 90 
percentage of the women was likely to develop pre eclampsia , but this test is 
invasive. 
Uterine artery Doppler 
o Non pregnant women  
 reduced diastolic flow and notching of the uterine artery 
o Normal pregnancy 
 Due to the trophoblastic invasion, the notch disappears and 
flow increases.  
“ IF THERE IS PERSISTENCE OF A DIASTOLIC NOTCH IN THE 
UTERINE ARTERY OR INCREASED RESISTANCE AT 20 -22 WEEKS- it 
indicates second stage of trophoblastic invasion has not occurred” 
 This helps in the prediction of pre eclampsia and IUGR. In general, the 
uterine Doppler test is the best among all the above said test as there is no other 
test are truly predictive. The latest combination method in first trimester include 
in prediction of pre eclampsia is uterine artery Doppler along with pregnancy 
associated plasma protein(PAPP- A) and placental protein 13(PP13). 
  
Methods of prevention  
1. Low salt diet  
 Salt restriction was the earliest research efforts to prevent pre 
eclampsia(De snoo 1937). In 1998, knuist and collegue reported that salt 
restricted diet was not effective in prevention of pre eclampsia. 
2. Calcium supplementation  
 In the 1980’s( Belizan and vilar ) studies were shown that patients with 
intake of low dietary calcium had increased the risk of pre eclampsia . 
 Following that there are various studies including the national institute of 
child health and human development (Levine and collegues 1997). Shown that 
unless the women has calcium deficient, calcium supplementation has no effects 
on reducing pre eclampsia . 
3. Fish oil supplementation 
 Eicosapentanoic acid  and alpha linoleic acid are the most common 
dietary source. It may prevent inflammatory mediated atherogenesis. But the 
randomised trials (Makrides 2006, olafsdottir 2006, olsen 2000, and their 
collegues)shown that there is no such benefits. 
 
 
  
4. Antioxidants  
 Vitamin C &E are the two naturally occurring anti oxidants  and there is 
reduction in the plasma level of these anti oxidants are noted in pre eclampsia.( 
Raijmakers and associates 2004). 
 Thus supplementation of anti oxidants improves the oxidative property of 
women who are risk of pre eclampsia. (Poston 2006, Rumbold 2006)  studies 
revealed that the  eclampsia  has not reduced by the use of antioxidants. 
5. Antithrombotic agents  
6. Low dose aspirin  
 Wallenburg and associates 1986. Daily oral dosage 50 to 150 mg of 
aspirin inhibits thromboxane A2 synthesis. The paris collaborative group 
performed a meta analysis which showed that the relative risk of pre eclampsia 
was reduced by 10%. 
7. Low dose aspirin + heparin  
 High incidence of thrombotic lesion in placenta was found in the patients 
of severe pre eclampsia. In the year 2006, sergis and associates analyses the 
effect of prophylaxis with low dose aspirin with low molecular heparin in 
random with history of early onset pre eclampsia and low birth weight babies. 
They reported that there is better pregnancy outcome in patients with low dose 
aspirin plus low molecular heparin than those with low dose aspirin alone. 
  
 
 
 
 
 
 
 
 
AIMS OF THE STUDY 
 
 
 
 
 
 
 
 
  
OBJECTIVES OF THE STUDY 
A study on strength of association between the changes in serum 
calcium, serum uric acid , urine albumin creatinine ratio and pre 
eclampsia and its outcome was done at Thanjavur Medical College 
And Hospital, Thanjavur. 
The prime objectives of this study are as follows, 
1. To estimate the strength of association between the changes 
in the serum uric acid, serum calcium, urine albumin 
creatinine ratio in pre eclampsia. 
2. To know whether these factor in pre eclampsia influence on 
maternal and perinatal outcome. 
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 MATERIALS AND METHODOLOGY 
A STUDY OF STRENGTH OF ASSOCIATION  BETWEEN  
CHANGES IN SERUM CALCIUM , SERUM URIC ACID , URINE 
ALBUMIN – CREATININE RATIO AND PRE ECLAMPSIA AND ITS 
IMPACT ON OUTCOME. 
This study was conducted in Thanjavur Medical College Hospital, 
Thanjavur, for a period of one year from September  2013 –  August 2014. 
The study groups participated voluntarily in this study and each of them 
gave informed consent. This study was approved by Ethical And Research 
Committee Of Thanjavur Medial College. 
Study  population 
 In this prospective study, total number of 100 subjects were participated , 
it includes 50 gestational hypertension patients as cases and 50 normotensive 
pregnant women as controls. Both these study groups were studied in their 28 – 
32 weeks of gestation.  
 The study groups includes both primi and multi parous pregnant women. 
They were selected on the basis of simple random sampling method. 
 
 
  
Inclusion criteria 
 Gestational hypertension patients and normotensive pregnant women 
between 28 – 32 weeks of gestation from 18 to 35 years of age. 
Exclusion criteria 
 Prior history of chronic renal disease, diabetes mellitus, chronic 
hypertension, twin gestation, UTI were excluded from the study. 
History regarding age, parity, socio economic status, past family and 
personal history was taken. General examination was done for blood pressure 
edema and weight gain. The investigations included  serum calcium, serum uric 
acid and spot urinary albumin - creatinine ratio. 
1. Collection of blood sample: 
Under aseptic precautions, 3ml of  venous blood was collected and 
allowed to clot. The serum separated was then used for the estimation of 
calcium and uric acid using Randox Daytona auto analyser. 
2. Collection of urine sample: 
The random midstream urine sample of 10 ml was collected in the sterile 
container without any preservatives and assayed for albumin and creatinine 
using Randox Daytone auto analyser. 
 
  
Evaluation 
 These patients were regularly examined during each antenatal visits till 
delivery. CBC, RBS, RFT, LFT, Serum calcium, serum uric acid, urine 
albumin/creatinine  ratio were monitored throughout the pregnancy period and 
its impact on the oucome was studied. 
 
Parameter Method 
Serum calcium Arzenazo III, calorimetric method 
Serum uric acid Enzyme method 
Urine albumin  Immune turbidimetric method 
Urine creatinine Jaffe’s method 
 
ESTIMATION OF SERUM CALCIUM 
Serum calcium was estimated by ARZENAZO – III , calorimetric method 
Randox auto analyser, using  RANDOX KIT. 
Principle  
Ca++   +   Arsenazo III       coloured complex 
“ Arsenazo III specifically bind to calcium and and forms a coloured complex 
which can be measured at 650 nm” 
  
The intensity of the coloured complex is directly proportional to the 
amount of calcium present in the sample. 
CONTENTS Initial concentration of the solution. 
R 1 ARSENAZO III REAGENT 
• Arsenazo  
• Sodium acetate 
• Non reactive stabilizer 
 
54.2 mmol/ L. Ph -5.9. 
Approximately 250 µ mol / L. 
 
 These reagents are stable upto the expiry date when it is stored at +15oC  
to +25oC.  
Assay protocol of serum calcium 
Wave length 630 nm 
Reaction temperature 37oC 
Curet  1 cm path length 
Units  Mg/dl 
 
 
 
  
ESTIMATION OF SERUM URIC ACID 
Serum uric acid was estimated using RANDOX KIT – UA 1614 in the 
Randox auto analyser by the “ENZYME METHOD “. 
Principle : 
“ U ric acid is converted in to allantoin and hydrogen peroxide by uricase. 
Under the influence of peroxidase, it oxidizes 3,5 – dichloro 2 hydroxy benzene 
sulphonic acid and 4 amino phenazone to form red violet quinoneimine” 
REAGENT COMPOSITION  
Content Concentration in the test 
Hepes buffer  200 mmol/L,  Ph – 7.55  
Uricase ≥200 U/L 
Peroxidase  >1000 U/L 
4 amino phenazone 0.25 mmol/L 
3,5 DCHBS 4mmol/ L 
Standard 595 µmol/L (10 mg/dl) 
 
Assay protocol of serum uric acid 
These reagents are stable upto the expiry date when it is stored at +2oC to 
+48oC and protected from light. 
  
Mode Endpoint  
Wave length 750 nm 
Reaction temperature 37oC 
Cuvet   1 cm path length 
Units mg / dl 
 
ESTIMATION OF URINARY ALBUMIN CREATININE RATIO 
Urinary albumin was estimated by immune turbidimetric method. 
Principle  
“ Turbidimetry based on the principle of agglutination reaction. It 
measures the reduction in the light transmitted .the urine sample is mixed with 
the activation buffers(R1) and anti human antibody solution and allowed to 
react. 
The albumin present in the test specimen forms an insoluble complex 
which produce the turbidity, measured at the wave length of 340 nm. The 
resulting turbidity corresponds to the concentration of the albumin in the test 
specimen. 
 
 
  
Assay protocol of urinary microalbumin 
WAVE LENGTH 340 nm 
REACTION TEMPERATURE 37oC 
CUVETTE 1cm path length 
 
ESTIMATION OF  URINARY CREATININE 
BY JAFFE’S METHOD 
Principle 
“In alkaline medium, the creatinine reacts with picric acid to form a 
reddish yellow complex, the intensity is  directly proportional to the 
concentration of creatinine in the specimen and can be measured at 520 nm”. 
Alkaline picrate reagent 
 4 parts of picric acid  +  1 part of sodium hydroxide reagent. 
The working reagent was stable for one day. 
 
 
 
 
  
Reagent composition 
Picric acid reagent 0.91 gm /dl (0.04M) 
Sodium hydroxide 10 gm /dl 
Stock creatinine standard 100 mg creatinine in  
100 ml of 0.01 N HCL 
Working creatinne standard (10 mg/dl) prepared by dissolving 10 
ml of stock standard in 0.01 N HCL to 
make upto 100ml. 
Sulphosalicylic acid 3g/dl 
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RESULTS 
  The results obtained from this present study were from a total number of 
100 subjects, who were categorised into  
 GROUP I – Normotensive pregnant women – 50 
 GROUP II – pre eclamptic pregnant women  – 50 
Following biochemical parameters are compared between  two groups 
 Serum calcium 
 Serum uric acid 
 Urinary albumin 
 Urinary creatinine. 
The following ratio is compared between two groups 
 Urinary albumin / creatinine. 
Statistical analysis 
 Data was expressed in terms of Mean ±SD. Chi square test was applied to 
estimate the difference between two groups. Unpaired  ‘t’ test was used to study 
the changes in serum uric acid , serum calcium and urinary albumin creatinine 
ratio.  
 
  
P value >0.05 was taken as non significant. 
 P value <0.05 was taken as significant. 
 P value <0.01 was taken as highly significant. 
 P value <0.001 was taken as very highly significant. 
AGE 
The age group of the subjects was between 18 – 35 years. The mean age 
and standard deviation in pre eclamptic patients was 24.48 ± 2.08 years and in 
controls it was 23.65±2.47 years. There was no statistical difference in age 
between two groups. 
TABLE NO :1Age distribution of cases 
Age group in years Cases number Cases percentage 
18 - 20  8  16% 
21 – 25 24  48% 
26 – 30  10 20% 
31-35 8 16% 
TOTAL 50  100% 
 
 
 
 Bar diagram 1 : Showing age distribution in pre eclampsia
TABLE NO 2: Age distribution of 
Age group in years 
18-20  
21-25 
26-30  
31-35 
TOTAL 
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 Bar diagram 2: Showing age distribution in normal healthy women 
(controls). 
PARITY 
 Among the pre eclamptic 
multigravida were 14. The control group included  28 primigravida and  22 
multigravida women. The cases and controls were also matched with respect to 
parity (p>0.05). 
 The findings show that the incidence of  
primigravida when compared with multiparous women.
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 Table no 3 :Parity distribution in study groups.
Gravida 
Primigravida 
Multigravida 
Total  
 
Bar diagram 3 : Parity distribution in study groups
 
 
 
 
 
0
10
20
30
40
32
18
 
 
Cases Controls 
32 28 
18 22 
50 50 
 
28
22
PARITY
primigravida
multigravida
 
 BLOOD PRESSURE  
Table no 4 : showing MEAN BP  ±SD
Group 
Cases 
Controls 
Data are shown as Mean ± SD
There is a high statistical difference in the blood pressure both systolic and 
diastolic between the two groups.
Bar diagram no 4 : Showing the blood pressure values in study group
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 of blood pressure in the study group
Mean SBP with SD 
(mm HG) 
Mean DBP with SD
(mm HG)
147.34 ± 12.84 100.28 ± 8.53
115.8 ± 9.02 81.2 ± 3.83
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SERUM CALCIUM 
Table no 5 : calcium levels in study groups 
PARAMETER CASES 
MEAN±SD 
CONTROLS 
MEAN±SD 
‘t’ value ‘p’ value Significance 
 Calcium 
mg/dl 
8.29±0.69 9.73±0.72 10.168 <0.0001 High 
 
 Sensitivity = 75% 
 
 Specificity = 85 % 
 
 Positive Predictive Value = 83.3 % 
 
 Negative Predictive Value = 77.2 % 
 
 Diagnostic Accuracy = 80% 
 
Pie chart 5 : Diagnostic value of serum calcium in study groups 
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 The [Mean ±SD] serum calcium levels in cases was 8.29 ±0.69 mg/dl and 
in controls 9.73±0.72 mg/dl. There is a high stastical 
calcium levels between the two groups.
Bar diagram no 6 :Serum calcium levels in cases and controls
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 COMPARISON OF SERUM URIC ACID
BETWEEN CASES AND CONTROLS
Table no 6 : serum uric acid in study groups
GROUPS 
 
Cases 
Controls 
t* 
P 
*-unpaired test 
The mean serum uric acid levels (mg/dl) in cases and in controls were 6.7 ±1.1 
and 4.26±1.03 respectively and it was highly significant (p
Bar diagram  no 7 : serum uric acid values in study groups
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SERUM URIC ACID 
(mg/dl) 
 
Range Mean ± SD
3.98 -8.61 6.7 ±1.1 
2.52 – 6.24 4.26±1.03
0.08  
0.0045 ,HS.  
HS – highly significant. 
- 0.0045).
 
2.5
 
 
 
 
  
Table no 7 :Diagnostic value of serum uric acid in pre eclampsia 
Serum uric acid 
(mg/dl) 
Cases Controls Total 
>6.2 34(68%) 10(20%) 44 
<6.2 16(32%) 40(80%) 56 
Total 50 50 100 
P=0.0045 , significant. 
 Sensitivity = 72.5 % 
 Specificity = 87.5% 
 Positive predictive value =85.3% 
 Negative predictive value =76% 
 Diagnostic accuracy = 80% 
Pie chart no 8: Diagnostic value of serum uric acid in study groups 
 
72.50%
87.50%
85.30%
76%
80%
TESTS
SENSITIVITY 
SPECIFICITY 
positive predictive value
negative predictive value
diagnostic accuracy
  
COMPARISON OF URINARY ALBUMIN LEVELS 
BETWEEN CASES AND CONTROLS 
Table No 8 : Urine Albumin Levels In Study Groups 
GROUPS  Urinary albumin (mg/ L) 
Controls Mean ±SD 28.1 ± 25.1 
 Range  8.0 – 120.0 
Cases  Mean ±SD 157.8 ± 48.7 
 Range  62.2 – 260.4 
CASES MEAN differences 129.6 
VS ‘t’ value* 16.9 
CONTROLS ‘p’ value <0.001, HS. 
*-unpaired test HS – highly significant. 
 
 
 
 
 
 
 
 
 
 Bar diagram  no 9 : U
The mean urinary albumin values found in the 
mg/dl, while in the cases it was 157.8 ± 48.7 mg/L. The mean difference 
between the two groups was 129.6 mg/day.
Stastical analysis using unpaired ‘t’ test showed that urinary albumin 
levels in the cases were significantly higher whe
value was highly significant (p<0.001) between the cases and controls.
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URINARY CREATININE LEVELS 
Table no 9: Urine Creatinine levels in study groups 
 GROUPS  Urinary creatinine 
(gm/day) 
Controls Mean ±SD 0.95 ± 0.16 
 Range  0.8 -1.6 
Cases  Mean ±SD 1.21±0.37 
 Range  0.80 – 1.88 
CASES MEAN differences 0.26 
VS ‘t’ value* 4.63 
CONTROLS ‘p’ value <0.001, HS. 
*-unpaired test HS – highly significant. 
The mean urinary creatinine values found in the controls was 0.95±0.16 
gm/day, while in the cases it was 1.21 ±0.37 gm/day. The mean differences 
between the two group was 0.26 gm/day. 
 Statistical analysis using unpaired ‘t’ test showed that the urinary 
creatinine levels in the cases were significantly higher when compared to 
controls. The p value was highly significant (p<0.001) between cases and 
controls. 
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COMPARISON OF URINARY ALBUMIN / CREATININE RATIO 
BETWEEN CASES AND CONTROLS 
Table no 10 : Urine Albumin / Creatinine ratio in study groups 
GROUPS  Urinary albumin / 
Creatinine ratio 
Controls Mean ±SD 0.06±0.05 
 Range  0.01-0.24 
Cases  Mean ±SD 0.21±0.08 
 Range  0.06-0.43 
CASES MEAN differences 0.15 
VS ‘t’ value* 10.3 
CONTROLS ‘p’ value <0.001, HS. 
 CUT OFF VALUE >0.14 
*-unpaired test HS – highly significant. 
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 The mean Urinary Albumin : Creatinine ratio found in the controls 
was 0.06 ±0.05, while in cases it was 0.21 ± 0.08. The mean difference between 
the two group was 0.15.  
Stastical analysis using unpaired ‘t’ test showed that the urinary albumin; 
creatinine ratio in the cases were significantly higher when compared to 
controls. The p values was highly significant (p<0.001 ) between cases and 
controls. The cut off value was taken as 0.14. values of more than 0.14 was 
found in the cases. 
ONSET OF LABOUR 
 The onset of labour of cases and controls are shown in the table 
Table no 11 : onset of labour 
Onset Cases Controls P value Statistical significance 
Induced 33(66%) 7(14%) <0.001 High 
Spontaneous 14(28%) 40(80%) <0.001 High 
 
Out of 50 patients in cases, 3 underwent elective caesarean. Out of  
remaining 47 patients in cases , 33(66%) were induced and 14(28%) went in to  
spontaneous labour. Out of 50 controls, 3 underwent elective caesarean section.  
Out of remaining 47 patients, 7 were induced and 40 went for spontaneous  
labour. There is a high statistical significance with respect to the onset of  
labour. 
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MODE OF DELIVERY 
  The mode of delivery in the study groups are shown in the following 
table 
Table no 12 : mode of delivery
Mode of 
delivery 
Cases 
Caesarean  28(56%)
Forceps 2(4%) 
vaginal 20(40%)
 
Out of the 50 cases , 28  were  delivered by caesarean, forceps were 
applied for 2 cases and the rest 20 were delivered vaginally.
 Out of 28 cesaresan in case group, 3 were planned for elective caesarean 
section, 1 due to abruption due to unfavourable cervix, 6 were due to IUGR 
with oligo hydraminos, 8 were due to failed induction, 4 due to fetal distress, 4 
due to CPD, 1 due to HELLP syndrome and 1 due to failure to progression.
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Controls  P  value  
 13(26%) <0.01 
2(4%) >0.05 
 35(70%) <0.05 
 
controls
induced 
spontaneous
 
Statistical  
Significance 
 
High 
None 
High 
 
 
 
 
 
  In controls, 13 patient
applied forceps, and the rest 35 were delivered vaginally.
 In the control groups out of 13 cesarean section, 4 were due to failed 
induction, 4 were due to CPD, 2 were due to oligohydraminos and 3 were due to
fetal distress. 
 Statistical analysis was done using fisher test, and there is a high 
statistical significance between the two groups with caesarean and vaginal mode 
of delivery. There is no significant statistical difference between the two groups 
with respect to forceps mode of delivery.
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COMPLICATIONS 
Table no 13 : complications 
Complications Cases Controls 
Abruption 1(2%) 0 
Eclampsia 1(2%) 0 
Imminent symptoms 7(14%) 0 
IUGR 23(46%) 1(2%) 
 
BIRTH WEIGHT 
Table no 14 :Birth weight of babies in cases and controls 
 Cases  Controls ‘t’ value ‘p’ value  Statistical 
significance 
Birth 
weight 
2.2±0.5 kg 2.6±0.3 kg 4.028 <0.001 High 
 
Mean birth weight of cases and controls were 2.2 ± 0.5 kg and 2.6 ± 0.3 kg 
respectively. There is high statistical significance between cases and controls. 
 
 
 Bar diagram no 15 :Birth weight of babies
Table No 15: Perinatal Outcome
Parameters Cases 
Apgar score  
< 7 at birth  
27 (53%)
Nicu 
admission 
15(22%) 
Perinatal 
mortality 
7(14%) 
Pre maturity 11(22%) 
Low birth 
weight 
29(58%) 
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Controls P value 
 6(12%) <0.001 
4(8%) <0.001 
0 <0.05 
4(8%) <0.001 
11(22%) <0.001 
cases controls
BIRTH WEIGHT
 
Significance 
High 
High 
High 
High 
High 
  
Out of 50 cases, 15 babies in the case group were shifted to NICU due to 
very low birth weight, pre term, respiratory distress due to magnesium sulphate 
administration. Apgar score of <7 at 5 minutes was seen in 9 babies  due to the 
above said reasons. Incidence of low birth weight was 58% and pre term was 
22%. 
 Out of 50 controls, 2 babies had < 7 apgar score  and NICU admission 
were 4, out of which 3 were due to meconium aspiration, one pre term and 
respiratory distress.. incidence of pre term was 8% and low birth weight in 
controls were 22%. 
 In case group,Seven cases (14%) of perinatal mortality.6 babies shifted to 
NICU due to low birth weight, birth asphyxia and respiratory distress. 1 baby 
was fresh still birth due to abruption. 
  There is statistically high significant difference in between cases and 
controls with respect to NICU admission and apgar score <7 at birth , perinatal 
mortality and low birth weight. 
 
 
 
 
  
CORRELATION OF SEVERITY 
 The correlation of serum calcium levels with systolic blood pressure  and 
diastolic blood pressure  is shown in the following tables. There is a high 
statistical significant correlation between  
• Serum calcium and systolic blood pressure (r -0.913) 
• Serum calcium and  diastolic blood pressure (r -0.8562) 
Table no 16 : Correlation of serum calcium with blood pressure. 
Parameter ‘r’ value ‘p’ value Statistical significance 
Systolic blood pressure (mm 
HG) 
-0.9103 <0.001 High 
Diastolic blood pressure(mm 
HG) 
-0.8562 <0.001 High 
r- karl pearson correlative co efficient 
 
 
 
 
 
  
Chart no 16 :Correlation of serum calcium with systolic blood pressure 
 
 
Chart no 17 :Correlation of serum calcium with diastolic blood pressure
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DISCUSSION 
The result of the present study showed that there is significant difference 
between the two groups that is the calcium levels were lower in patients with 
pre eclampsia than that of normal pregnant women. 
COMPARISON OF SERUM CALCIUM 
Authors Cases  
(mg/dl) 
Controls 
(mg/dl) 
Numbers in 
each group 
P value 
Seema et al  8.3 ± 0.13 9.6 ± 0.18 50 <0.001 
Suleyman et al  8.6 ± 0.5 9.4 ± 0.72 50 <0.001 
Soe min et al  8.8 ± 0.7 9.8 ± 0.9 25 <0.001 
Idougon et al  9.2  ± 1.02 9.8 ± 0.87 25 <0.001 
Golmohammed 
et al 
8.70 ± 0.58 8.97 ± 0.49 52 >0.05 
Chanvity et al  8.70 ± 0.59 8.99 ± 0.31 50 >0.05 
Sukonpan et al  9.0 ± 0.4 9.7 ±0.7 40 <0.0001 
Present study 8.2 ± 0.6 9.7 ± 0.7 50 <0.001 
 
The present study was similar to the results obtained by the above studies. 
These datas suggested that calcium might be the cause of development of 
pre eclampsia. when serum calcium decreases, there is increase in intracellular 
  
calcium which leads to constriction of smooth muscles and increase in vascular 
resistance. 
There are some studies that may be contradictory, which proposed that 
the serum calcium level in pre eclampsia was not different from normal 
pregnancy. “ This may be a caused by a mislead between chronic hypertension 
or renal disease and pre eclamptic condition during pregnancy, the difference in 
the time of sample collection or the difference of dietary intake.” 
“ In this study serum calcium were estimated after the onset of pre 
eclampsia  and it is significantly lower than the normal pregnant women. now a 
days studies came out regarding the estimation of calcium at an early gestational 
age and it can be used as a predictor of pre eclampsia” 
“The limitations of the study are that the dietary intake of calcium are not 
taken in to consideration “supplementation of calcium in pregnant women in 
developing country helps us in reducing the incidence of pre eclampsia “ 
Endothelial dysfunction is the predominant pathology which occurs as 
early as 8-18 weeks but the signs and symptoms occur in the late trimester. In 
order to arrest the progression of disease in the initial stages, there are various 
predictors of pre eclampsia have been prepared .proteinuria and alterations in 
calcium and uric acid metabolism are common features of various forms of 
hypertension.  
  
There is statistically significant increase in the levels of serum uric acid in 
cases (p = 0.0045). The diagnostic accuracy was 80 % and there is a highly 
significant, positive correlation between serum uric acid and diastolic blood 
pressure. 
This is in accordance with the study done by the salih f et al , who also 
showed that there is significant increase in serum uric acid levels in pre 
eclampsia and it was a good predictor of maternal disease progression and fetal 
outcome. 
Bainbridge S A et al showed that there is a significant relation between 
hyperuricemia and pre eclampsia, where serum uric acid  was a independent 
pathogenic agent. 
Gulati R and Roberts J M et al showed that there is a significant increase 
in the serum uric acid level in pre eclampsia patients and associated with risks 
of adverse outcome. Koopmans C M et al , in their bivariate meta analysis , 
revealed that the measurements of serum uric acid was useful test to predict the 
maternal complications of preeclampsia. 
To predict the maternal complications in the management of women with 
pre eclampsia. They also suggest that in patients with  increased serum uric acid 
levels. Labour should be induced due to their increased risk of complications. 
  
In the present study, the mean urinary albumin values found in the 
controls was 28.1±25.1 mg/dl, while in the cases it was 157.8 ± 48.7 mg/L. The 
present study  showed that urinary albumin levels in the pre eclamptic women 
were significantly higher when compared to normal pregnant women. The p 
value was highly significant (p<0.001). 
These findings are in accordance with the studies of  Poon LCY et al, 
Daya sirohiwal et al, Misiani R et al, Hellen Rodriguez et al. Their findings  are 
that the normotensive women who later developed  hypertension in the 
pregnancy, was found to have micro albumin excreted in urine in a significant 
amount. 
In the present study, the urinary microalbumin /creatinine ratio was 
higher in women with gestational hypertension when compared with 
normotensive pregnant women. the cut off value was 0.14. a ratio of more than 
0.14 was seen in the women with gestational hypertension. This was statistically 
significant with a p value of <0.001. 
This is in accordance with the studies done by Neithardt ABet.al, 
Jaschevatzky OE et.al, Risberg A et.al, Nisell H et.al, Misiani R et.al, Poon  
LCY et.al,Kok-min seow et.al, Frank P. Schubert et.al,Higby Kenneth et.al. 
In our study, with a cut off value of 0.14 the ratio of 
microalbumin/creatininehas a sensitivity of 86%, specificity of 84%, positive 
  
predictive value of 85%,negative predictive value of 86% and diagnostic 
accuracy of 85%.The most prevalent quantitative assessment of the amount of 
protein excretedin the urine for the diagnosis of pre-eclampsia is a 24- hour 
urine collection.  
However,the collection and analysis of 24-hour urine specimens is 
cumbersome and time consuming for both patient and the laboratory. This has 
lead to the use of singlevoided urine protein/creatinine ratio to estimate 
proteinuria. This is because the ratioof 2 stable excretion rates, creatinine and 
protein would cancel out the time factorand thus provide a better estimate of 24-
hour protein excretion. 
 Hence, themicroalbumin/creatinine ratio was used in our study to 
estimate microalbuminuria.Also few studies have suggested that a 
protein/creatinine ratio of <0.2 rules out thepresence of significant proteinuria 
(>300mg/L) which correlates well with our study. 
In our study the mean value of urinary creatinine found in the controls are 
0.95 ± 0.16 gm/day, while in the cases it was 1.21 ± 0.37 gm/day. It was 
statistically significant (p<0.001) between cases and controls. 
 In our study, the caesarean rate was 56% among the pre eclampsia 
patients. The caesarean rate in other similar studies were 72% in Tuffnell et al, 
54% in Al Inizi et al, 79% in Sibai et al. 
  
 There is no maternal mortality in this present study. The complications 
were abruption in 1 case, eclampsia in 1 case, imminent ecalmpsia in 7 cases. 
The overall complications rate in our study is 18%  which is statistically less 
when compared with various other studies. This is achieved through the close 
followup and monitoring of the patients. 
In this study, the perinatal mortality was  around 14% , NICU admissions 
were about 22%.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
SUMMARY 
 
 
 
 
 
 
 
  
SUMMARY 
A study of strength of association  between  changes in serum calcium 
, serum uric acid , urine albumin – creatinine ratio and pre eclampsia and 
its impact on outcome. 
This study was done at Thanjavur Medical College Hospital, Thanjavur. 
 50 women with pre eclampsia  as cases and 50 normal healthy pregnant 
women as controls were selected for the study.  
 There was a decrease in serum calcium levels and increase in serum uric acid 
in pre eclamptic patients when compared with normal healthy pregnant 
women. The changes in calcium and uric acid were statistically significant . 
 The urinary albumin creatinine ratio in cases of pre eclampsia when 
compared to controls was statistically significant(p<0.01). 
The present study showed  hypocalcemia and hyperuricemia in pre 
eclampsia, suggesting the role of calcium and uric acid in the etiology of pre 
eclampsia , though the exact mechanism remains to be  elucidated.  
The strength of association between these factors and pre eclampsia are 
very much significant. These factors are much useful in the earlier period of 
gestation in the screening of pre eclampsia.  
In this study  caesarean rates in the pregnant women are higher among the 
pre eclampsia patients. In this study there is no maternal mortality, CVA or 
  
severe acute renal failure. Despite the use of magnesium sulphate and careful 
control of blood pressure e had, one case of eclampsia and 1 case of abruption 
with IUD. Among the perinatal outcome, incidence of IUGR  babies, NICU 
admissions  are more common among the babies of pre eclampsia. 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 
  
CONCLUSION 
But it remains to be known whether these changes are a cause and 
consequences of the disease. It is not clear which is the primary event that 
trigger the onset of hypertension in pre eclampsia. 
Ongoing research shows abundant evidence that the pathophysiological 
changes of pre eclampsia are present long before the  clinical presentation of the 
disease, which probably explains why all the management of PIH, other than the 
delivery are only palliative. 
In this study, by the help of careful and close monitoring of the patients, 
the maternal mortality is avoided and maternal morbidity is greatly reduced. 
The factors like serum calcium, serum uric acid and urine albumin/ 
creatinine ratio are strongly associated with pre eclampsia. These biochemical 
changes  appears  well before their clinical presentation.  
Among Maternal mortality world wide, 10 -15 % were due to pre 
eclampisa and eclampsia. Despite advances in medical practice, pre eclampsia 
has remained a leading cause of maternal mortality throughout the world. Our 
hospital is a major referral centre. So there is relatively high prevalence of  pre 
eclampsia in our population. Close and frequent observation of  maternal and 
fetal status of pre eclampsia in a tertiary care centre, is associated with a good 
perinatal outcome and reduced risk of complications for the mother.  
  
Thus it can be concluded that , the careful monitoring of these markers in 
pregnant women may help in the mortality and morbidity reduction and thereby 
helpful  in the favourable outcome of the pregnancy. 
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consent to participate in the  study conducted by       DR.M.KOKILAVANI, 
post graduate in department  of Obstetrics and Gynaecology, Thanjavur medical 
college & hospital, Thanjavur -613001 and to use my personal clinical data and 
result of investigation for the purpose of analysis and to study the nature of 
disease. I also give consent for further  investigations. 
      
 
 
Place :       Signature  of participant  
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PROFORMA 
 
I. Particulars 
1. Name  
2. Age 
3. Religion      
4. Address 
5. Occupation       
6. Educational status 
7. Socio economic status 
8. Date of admission  
9. In patient / out patient number  
 
II. History : Duration of amennorhoea, history suggestive of pre 
eclampsia 
III. Obstetric history married life, consanguinity, obstetric index, history 
of present pregnancy 
IV. Menstrual history : previous cycles, regularity, last menstrual period 
(LMP) and period of gestation 
V. Past history: H/O hypertension, diabetes mellitus. 
VI. Family history : h/o diabetes mellitus, hypertension, pre eclampsia in 
mother  
 
VII. General physical examination 
Height    pallor    thyroid  
weight   icterus    breast  
BMI     edema    spine  
  
 
VIII. Vital data  
Temperature      Resting Pulse Rate 
Systolic BP 
Diastolic BP    Rate of respiration 
 
IX. Systemic examination 
1. Respiratory system 
2. CVS  
3. CNS  
4. Per abdomen examination 
• Abdominal wall edema  
• Uterine size(gestational age) 
• Fetal heart rate and fetal movements 
 
X. Investigations  
Hb%     blood group  
urine albumin    urine creatinine   ratio 
serum calcium    serum uric acid  
 
XI. Outcome measures 
 
 Maternal complications : abruption  imminent symptoms, eclampsia, IUGR. 
 Onset of labour : induced or spontaneous. 
 Mode of delivery : vaginal, caesarean and its indications, instrumental 
delivery. 
 Baby details : birth weight, date of birth, APGAR score, NICU 
admission. 
 
  
 
 
 
 
 
 
 
 
 
MASTER CHART 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Key To Master Chart 
 
1. Sl.no – serial number 
2. OP/IP no - Outpatient/ Inpatient Number 
3. POG - period of gestation 
4. SBP - systolic blood pressure 
5. DBP - diastolic blood pressure 
6. Sr.Ca – serum calcium 
7. Sr.UA – serum uric acid 
8. U.Alb – urine albumin 
9. U.Cre- urine creatinine 
10. U.A/C – urine albumin/creatinine  
11. COMP – complications 
12. MOD – mode of delivery 
13. BW – birth weight 
14. igr- intrauterine growth retardation 
15. oligos- oligohydraminos 
16. im – imminent eclampsia 
17. cs- caesarean  
18. v- vaginal 
  
Sl. 
No. 
Name Age OP/IP POG Parity SBP DBP Sr.Ca Sr.UA U.Alb U.Cre U.A/C Comp MOD BW A1 A5 
1. KARTHIKA 21 217621 28 PRIMI 128 78 10.2 3.95 26.12 0.83 0.04 - 0 2.9 7 9 
2. MAHESWARI 18 218253 29 PRIMI 130 72 10.6 4.63 18.23 0.82 0.03 - v 3 8 10 
3. SARASWATHI 23 217832 32 MULTI 122 76 9.6 4.96 16.31 1 0.24 - v 3.7 7 9 
4. LAKSHMI 19 2179116 30 PRIMI 110 70 8.5 5.03 10.81 0.89 0.16 - v 2.8 6 10 
5. PARVATHI 23 2178262 28 PRIMI 130 78 8.9 6.91 10.81 0.96 0.02 - v 2.6 8 10 
6. KALA 30 218242 29 MULTI 126 80 10.7 2.81 17.92 0.9 0.029 - v 2.7 6 9 
7. MANIMEGALAI 32 217849 31 MULTI 124 84 9.8 3.76 14.01 0.84 0.025 - v 2.9 7 10 
8. MEERA 24 218259 32 PRIMI 120 86 8.5 3.85 25.43 1.05 0.03 - v 3.2 7 9 
9. BRINDHA 29 218654 28 MULTI 126 88 8.7 2.98 10.45 0.94 0.01 - v 3. 7 10 
10. CHITRA 26 217959 30 PRIMI 122 70 9.6 3.58 10.92 0.82 0.02 - v 2.8 7 9 
11. DEVIKA 20 269658 32 PRIMI 130 78 9.8 2.64 17.43 0.84 0.03 - v 3.1 7 10 
12. ARCHANA 25 225849 28 PRIMI 110 76 9.3 4.51 22.43 0.8 0.04 - v 2.5 7 10 
13. SARALA 29 217640 29 MULTI 110 70 9 5.08 19.4 0.94 0.03 - Cs 2.7 7 9 
14. VEERALAKSHMI 31 217242 31 MULTI 128 72 9.6 5.13 26.19 0.9 0.03 - v 2.2 7 10 
15. MEENA 34 218061 30 MULTI 120 82 9.8 6.31 18.81 0.96 0.03 - Cs 2.8 7 9 
16. VIJAYA 22 217521 32 PRIMI 124 86 9 3.81 10.23 1.2 0.015 - o 2.9 7 10 
17. UMA 35 216253 28 MULTI 130 88 9.2 6.14 19.01 1.04 0.023 - Cs 2.6 5 10 
18. MARI 23 218261 29 PRIMI 110 80 9 5.98 24.08 0.98 0.034 - Cs 2.8 7 10 
19. SOOSAI AMMAL 28 217267 32 PRIMI 118 82 9.6 2.59 28.16 1.6 0.043 - v 2.4 7 10 
20. VANATHY  18 217521 31 PRIMI 110 80 9.4 3.95 14.23 0.89 0.013 - v 3.1 6 10 
21. KUMUDHA 26 218651 30 MULTI 118 84 10.4 6.61 19.24 0.92 0.032 - v 2.9 7 7 
22. KEERTHI 22 217451 28 PRIMI 100 88 9.6 4.81 22.46 0.84 0.036 - v 2.8 7 10 
23. AMARAVATHY 27 217662 32 PRIMI 114 78 10.6 4.13 12.12 0.8 0.051 - Cs 3.6 8 10 
24. VINITHA 19 217567 28 PRIMI 100 76 12 2.54 28.4 0.98 0.03 - v 3 8 10 
25. SANGEETHA 23 218452 28 PRIMI 110 80 9 3.91 20.22 0.94 0.03 - Cs 2.9 6 9 
 
MASTER CHART – CONTROL 
  
 
Sl. 
No. 
Name Age OP/IP POG Parity SBP DBP Sr.Ca Sr.UA U.Alb U.Cre U.A/C Comp MOD BW A1 A5 
26. MALA 21 218655 30 PRIMI 110 86 9.6 2.52 8.04 0.94 0.012 - V 2.8 8 10 
27. VASUKI 22 218756 30 PRIMI 110 90 8.9 3.11 10.23 1 0.10. - V 3.1 8 10 
28. SEETHA 26 217769 32 MULTI 102 88 10.8 6.98 14.62 1.12 0.019 - CS 2.9 8 10 
29. RAMYA 18 217821 31 PRIMI  109 90 10 4.16 29.16 0.82 0.053 - V 2.5 8 10 
30. JAYALAKSHMI 29 217420 29 MULTI 100 90 10.6 4.81 42.03 0.89 0.07 - V 2.8 8 9 
31. PRIYA 24 218521 28 PRIMI 110 86 10.2 4.12 18.26 1.22 0.06 - V 2.5 7 10 
32. SAKUNTHALA 25 218650 30 MULTI 114 84 9 3.96 9.42 0.9 0.04 - V 2.5 7 9 
33. VASANTHA 33 218424 32 MULTI 116 80 10.4 4.05 26.12 0.98 0.06 - V 2.6 8 9 
34. DEVI 24 217626 29 PRIMI 120 82 10.4 6.16 14.88 1.36 0.09 - V 3 8 10 
35. ANANDHI 19 217957 31 PRIMI 122 86 10.5 4.4 11.04 0.86 0.09 - V 3.1 8 10 
36. VICHITRA 23 217856 30 PRIMI 134 90 9.5 4.81 13.29 1.2 0.037 - CS 2.7 7 10 
37. MANGAMMA 22 218324 32 PRIMI 108 80 9.1 3.21 26.12 1.04 0.014 - V 2.3 8 10 
38. RATHINA 22 217256 28 PRIMI 110 84 10.2 2.96 12.01 1.28 0.012 - V 8.6 9 10 
39. PAPPAMMAL 19 218426 28 PRIMI 100 88 9.1 5.92 8.24 0.98 0.05 - CS 3 9 9 
40. KURUVAMMA 35 218627 30 MULTI 110 78 9.3 3.01 24.12 0.8 0.03 - V 2.9 8 10 
41. ANITHA 26 218523 32 MULTI 110 80 9.2 4.86 18.46 0.89 0.05 - V 2.5 7 10 
42. MALARVIZHI 31 216273 31 MULTI 112 82 10.4 6.01 29.26 0.92 0.08 - V 2.8 7 9 
43. BHUVANESWARI 32 221121 29 MULTI 122 86 10.3 3.88 46.04 0.9 0.06 - CS 3 8 10 
44. GEETHA 20 217723 30 PRIMI 110 70 9.3 4.02 34.4 0.8 0.18 - V 2.9 9 9 
45. VINOTHINI 28 217251 28 MULTI 108 70 10.4 3.56 96.23 0.8 0.15 - V 3.1 9 8 
46. SRINATH 27 217621 29 MULTI 100 78 10.6 6.04 84.04 0.82 0.12 - V 3.2 8 9 
47. NIRMALA 26 217851 32 MULTI 126 72 10.2 4.56 72.13 0.9 0.15 - V 2.9 9 10 
48. BANUMATHI 27 217961 32 MULTI 130 88 9.1 5.40 80.42 0.8 0.16 - CS 2.6 9 10 
49. INDHUMATHI 35 218962 28 MULTI 110 82 10 5.01 92.01 0.84 0.06 - V 2.7 8 9 
50. THENMOZHI 18 218021 28 MULTI 128 80 9.2 3.98 30.16 0.8 0.21 - CS 2.8 8 10 
  
 MASTER CHART - CASES 
Sl. 
No. 
Name Age OP/IP DOA Parity SBP DBP Ca VA U.Ab U.Cre U.A/c Comp MOD BW A1 A5 
1. RADHA 21 209261 28 PRIMI 138 90 10.3 6.7 62.18 1.26 0.074 igr v 1.2 4 6 
2. KAMALA 19 209178 30 PRIMI 140 98 8.1 7.1 78.42 1.88 0.062 igr v 2 6 8 
3. VIJI 23 208248 29 MULTI 142 100 8 6.9 101.24 0.98 0.155  o 2.9 6 8 
4. SRIDEVI 18 209642 31 PRIMI 144 102 8.3 6.01 124.12 1.31 0.142  v 1.9 6 6 
5. RAJI 24 207245 32 PRIMI 152 110 8.1 7.8 132.42 1.45 0.137 igr  cs 1.0 2 4 
6. VANI 30 217628 30 MULTI 160 130 7.2 6.5 145.16 1.53 0.142 igr cs 2.8 8 8 
7. JANAKI 26 208246 28 PRIMI 138 120 7.6 7.1 139.42 1.24 0.168 igr v 2.9 6 8 
8. AMBIKA 24 207245 29 PRIMI 140 100 6.6 6.9 148.64 1.84 0.135 eclamp cs 2.8 6 8 
9. SHENBAGAM 31 217720 32 MULTI 140 104 7.6 7.2 201.21 1.72 0.175  cs 2.1 0 0 
10. AANANDHI 23 208242 28 PRIMI 150 100 10 8.1 192.45 1.62 0.178 igr v 2.2 6 8 
11. KAVITHA 20 207646 30 PRIMI 155 115 8.1 5.3 183.56 1.8 0.152  cs 3.0 8 9 
12. DEEPA 25 207847 31 PRIMI 150 100 8.7 6.8 168.18 1.78 0.141  cs 1.8 8 8 
13. SUMITHRA 35 217842 28 MULTI 150 100 8.2 6.0 245.12 1.82 0.202  cs 2.7 6 8 
14. RAMA 22 218241 29 PRIMI 140 90 8.6 6.8 155.62 1.62 0.138 igr, im v 1.0 5 6 
15. DEVI 24 209842 32 PRIMI 162 138 8.5 8.0 172.46 0.96 0.269 igrc cs 2.2 7 8 
16. RANI 27 202470 28 MULTI 140 92 6.8 5.9 79.12 1.62 0.073  cs 2.6 6 8 
17. PRIYA 23 202410 29 PRIMI 150 94 8.2 6.9 156.82 1.24 0.189 igr v 1.3 5 7 
18. RAGANI 28 216470 30 MULTI  144 90 8.6 4.7 114.12 0.92 0.186  v 2.4 6 8 
19. MEGALA 20 211210 32 PRIMI 152 98 8.6 5.8 180.24 1.53 0.176  cs 3.4 8 9 
20. SATHYA 29 208210 28 MULTI 138 100 8.8 6.3 100.48 0.94 0.16 im cs 2.5 9 9 
21. VANITHA  23 218210 28 PRIMI 140 98 7.9 6.7 128.26 1.23 0.156  v 9.00 8 9 
22. VALARMATHI 34 209260 29 MULTI 148 110 8.8 7.1 158.42 0.86 0.276 igr v 1.1 6 8 
23. KALA 22 207216 30 PRIMI 150 110 8.2 7.6 172.12 0.9 0.286 igr. im cs 1.5 7 6 
24. SHARMILA 21 206215 28 PRIMI 146 98 8 5.9 208.42 1.14 0.274 igr cs 1.8 6 8 
25. VIMALA 31 219621 32 MULTI 160 100 7.4 5.9 236.08 1.26 0.281  v 2.6 8 10 
 
  
Sl. 
No. 
Name Age OP/IP DOA Parity SBP DBP Ca VA U.Ab U.Cre U.A/c Comp MOD BW A1 A5 
26. DIVYA 21 228920 28 PRIMI 156 110 7.5 7.8 242.12 1.42 0.255 igr cs 2.4 8 8 
27. VIDHYA 23 202965 29 MULTI 142 92 8.7 6.8 149.42 1.6 0.14 im v 2.5 8 10 
28. PARVEEN 20 219625 30 PRIMI 140 90 8.7 8.4 182.64 0.9 0.301  cs 2.8 6 8 
29. NOORJAHAN 24 218735 28 PRIMI 150 110 7.7 5.3 212.12 0.88 0.361  o 2.6 7 8 
30. PALANIAMMAL 28 221360 32 MULTI 154 98 8.3 7.1 78.42 0.8 0.147 igr v 1.2 7 8 
31. NADHIYA 25 231250 28 PRIMI 140 98 8.7 4.3 92.16 0.98 0.141  cs 3.2 8 9 
32. ILAVARASI 32 221069 32 MULTI 150 98 8.6 8.6 88.44 0.82 0.162 igr fv 2.2 4 8 
33. MARY 22 217605 30 PRIMI 148 90 8 7.1 108.46 0.86 0.131  cs 2.5 8 8 
34. KAMATCHI 18 218302 29 PRIMI 150 110 9.3 4.3 112.42 0.98 0.196 igr v 1.1 6 7 
35. VADIVU 27 219305 31 MULTI 148 100 8.8 6.9 118.23 0.94 0.182 igr cs 2.4 8 8 
36. JULIE 23 208709 28 PRIMI 140 90 8.6 3.9 122.16 1.24 0.195  cs 3.4 6 8 
37. BANUMATHY 33 217302 28 MULTI 140 90 8.2 6.6 148.19 1.86 0.142 im cs 2.2 6 8 
38. MALLIKA 22 216305 30 PRIMI 155 98 8.8 7.9 154.16 0.86 0.269  o 2.9 6 8 
39. KIRUTHIKA 24 218358 32 MULTI 144 96 8.6 8.0 198.49 0.92 0.323 igr cs 2.4 8 9 
40. HARINI 29 205670 31 PRIMI 160 90 8.1 6.9 128.42 0.98 0.2  cs 2.4 6 8 
41. RANI 23 225790 29 PRIMI 150 110 7.8 6.4 200.16 1.16 0.26 igr v 1.2 8 10 
42. JAMILABEGAM 19 218630 28 PRIMI 146 94 8.6 7.2 214.24 1.26 0.26  cs 2.5 5 8 
43. VISHALATCHI 30 217920 32 MULTI 160 110 7.6 6.8 140.26 0.9 0.23 igr v 2.1 8 10 
44. NAGALAKSHMI 24 208020 28 PRIMI 144 90 7.6 8.0 158.42 0.88 0.27 igr v 1.2 6 8 
45. VIJAYA 26 217201 28 PRIMI 130 94 9.3 6.4 246.02 1.88 0.20  v 2.4 8 10 
46. LAKSHMI 23 218920 29 PRIMI 140 98 9.1 7.2 148.16 0.8 0.28 igr cs 2.1 4 10 
47. MARY 31 212035 30 MULTI 150 90 8.5 6.6 178.02 0.82 0.32  V 1.1 4 6 
48. JASMINE 19 218612 32 PRIMI 140 100 8.2 6.4 188.09 0.8 0.35 im v 2.5 7 8 
49. NIVEDHA 23 207241 32 PRIMI 150 90 8.4 7.4 192.4 0.8 0.36  v 2.3 8 10 
50. SHYLAJA 35 217291 28 MULTI 140 90 9.0 8 180.2 0.92 0.26 igr cs 2.7 8 8 
 
